




Analysis Type:	PANTHER Overrepresentation Test (Released 20210224)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4735677 Released 2021-05-01
Analyzed List:	Client Text Box Input (Homo sapiens)
Reference List:	Homo sapiens (all genes in database)
Test Type:	FISHER
Correction:	FDR
GO biological process complete	Homo sapiens - REFLIST (20595)	Client Text Box Input (3008)	Client Text Box Input (expected)	Client Text Box Input (over/under)	Client Text Box Input (fold Enrichment)	Client Text Box Input (raw P-value)	Client Text Box Input (FDR)
gene silencing by RNA (GO:0031047)	89	3	13.00	-	.23	4.10E-03	4.99E-02
detection of abiotic stimulus (GO:0009582)	139	36	20.30	+	1.77	4.09E-03	4.99E-02
long-term synaptic potentiation (GO:0060291)	48	17	7.01	+	2.42	4.09E-03	4.99E-02
renal system process (GO:0003014)	116	31	16.94	+	1.83	4.08E-03	4.98E-02
regulation of muscle tissue development (GO:1901861)	41	15	5.99	+	2.50	4.04E-03	4.94E-02
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)	41	15	5.99	+	2.50	4.04E-03	4.93E-02
detection of mechanical stimulus (GO:0050982)	54	18	7.89	+	2.28	4.01E-03	4.92E-02
cellular response to zinc ion (GO:0071294)	25	11	3.65	+	3.01	4.01E-03	4.91E-02
cell proliferation in forebrain (GO:0021846)	25	11	3.65	+	3.01	4.01E-03	4.91E-02
cellular response to corticosteroid stimulus (GO:0071384)	62	20	9.06	+	2.21	4.00E-03	4.91E-02
positive regulation of phospholipase activity (GO:0010518)	62	20	9.06	+	2.21	4.00E-03	4.91E-02
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	126	33	18.40	+	1.79	4.00E-03	4.90E-02
hemopoiesis (GO:0030097)	585	115	85.44	+	1.35	3.96E-03	4.87E-02
response to other organism (GO:0051707)	1425	166	208.13	-	.80	3.94E-03	4.84E-02
positive regulation of apoptotic process (GO:0043065)	560	111	81.79	+	1.36	3.93E-03	4.84E-02
establishment of protein localization to membrane (GO:0090150)	313	26	45.72	-	.57	3.93E-03	4.84E-02
DNA packaging (GO:0006323)	202	14	29.50	-	.47	3.91E-03	4.82E-02
blastoderm segmentation (GO:0007350)	21	10	3.07	+	3.26	3.88E-03	4.80E-02
linoleic acid metabolic process (GO:0043651)	21	10	3.07	+	3.26	3.88E-03	4.79E-02
protein phosphorylation (GO:0006468)	685	132	100.05	+	1.32	3.88E-03	4.79E-02
regulation of endothelial cell proliferation (GO:0001936)	135	35	19.72	+	1.78	3.68E-03	4.55E-02
inorganic ion import across plasma membrane (GO:0099587)	85	25	12.41	+	2.01	3.66E-03	4.53E-02
inorganic cation import across plasma membrane (GO:0098659)	85	25	12.41	+	2.01	3.66E-03	4.53E-02
regulation of corticosteroid hormone secretion (GO:2000846)	17	9	2.48	+	3.62	3.56E-03	4.44E-02
spinal cord dorsal/ventral patterning (GO:0021513)	17	9	2.48	+	3.62	3.56E-03	4.44E-02
post-anal tail morphogenesis (GO:0036342)	17	9	2.48	+	3.62	3.56E-03	4.43E-02
positive regulation of cardiocyte differentiation (GO:1905209)	17	9	2.48	+	3.62	3.56E-03	4.43E-02
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	17	9	2.48	+	3.62	3.56E-03	4.43E-02
stabilization of membrane potential (GO:0030322)	17	9	2.48	+	3.62	3.56E-03	4.42E-02
tooth mineralization (GO:0034505)	17	9	2.48	+	3.62	3.56E-03	4.42E-02
mesenchymal cell proliferation (GO:0010463)	17	9	2.48	+	3.62	3.56E-03	4.42E-02
fat cell differentiation (GO:0045444)	103	29	15.04	+	1.93	3.53E-03	4.41E-02
proteoglycan biosynthetic process (GO:0030166)	60	20	8.76	+	2.28	3.53E-03	4.41E-02
negative regulation of phosphorylation (GO:0042326)	395	83	57.69	+	1.44	3.50E-03	4.38E-02
regulation of response to external stimulus (GO:0032101)	1199	217	175.12	+	1.24	3.49E-03	4.36E-02
regulation of biomineral tissue development (GO:0070167)	93	27	13.58	+	1.99	3.46E-03	4.33E-02
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	208	49	30.38	+	1.61	3.45E-03	4.32E-02
positive regulation of lipid transport (GO:0032370)	84	25	12.27	+	2.04	3.45E-03	4.32E-02
positive regulation of protein kinase B signaling (GO:0051897)	181	44	26.44	+	1.66	3.43E-03	4.30E-02
metencephalon development (GO:0022037)	112	31	16.36	+	1.90	3.42E-03	4.30E-02
regulation of inflammatory response (GO:0050727)	518	104	75.66	+	1.37	3.41E-03	4.28E-02
regulation of cold-induced thermogenesis (GO:0120161)	144	37	21.03	+	1.76	3.38E-03	4.25E-02
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	76	2	11.10	-	.18	3.32E-03	4.17E-02
cardiac muscle cell myoblast differentiation (GO:0060379)	10	7	1.46	+	4.79	3.28E-03	4.17E-02
dorsal/ventral axis specification (GO:0009950)	10	7	1.46	+	4.79	3.28E-03	4.16E-02
post-embryonic development (GO:0009791)	83	25	12.12	+	2.06	3.28E-03	4.16E-02
ureter morphogenesis (GO:0072197)	7	6	1.02	+	5.87	3.28E-03	4.16E-02
amylin receptor signaling pathway (GO:0097647)	7	6	1.02	+	5.87	3.28E-03	4.16E-02
transcription elongation from RNA polymerase II promoter (GO:0006368)	75	2	10.95	-	.18	3.30E-03	4.15E-02
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	7	6	1.02	+	5.87	3.28E-03	4.15E-02
SA node cell action potential (GO:0086015)	7	6	1.02	+	5.87	3.28E-03	4.15E-02
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	7	6	1.02	+	5.87	3.28E-03	4.15E-02
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	7	6	1.02	+	5.87	3.28E-03	4.14E-02
cerebral cortex GABAergic interneuron development (GO:0021894)	7	6	1.02	+	5.87	3.28E-03	4.14E-02
cell-cell signaling by wnt (GO:0198738)	350	75	51.12	+	1.47	3.25E-03	4.13E-02
vacuole organization (GO:0007033)	145	8	21.18	-	.38	3.24E-03	4.13E-02
Wnt signaling pathway (GO:0016055)	350	75	51.12	+	1.47	3.25E-03	4.12E-02
membrane depolarization (GO:0051899)	52	18	7.59	+	2.37	3.23E-03	4.11E-02
positive regulation of cellular component biogenesis (GO:0044089)	534	107	77.99	+	1.37	3.21E-03	4.09E-02
regulation of cell-substrate adhesion (GO:0010810)	218	51	31.84	+	1.60	3.19E-03	4.07E-02
telomere organization (GO:0032200)	103	4	15.04	-	.27	3.16E-03	4.04E-02
nucleosome organization (GO:0034728)	156	9	22.78	-	.40	3.14E-03	4.03E-02
lymph vessel development (GO:0001945)	24	11	3.51	+	3.14	3.14E-03	4.03E-02
cellular response to vitamin (GO:0071295)	24	11	3.51	+	3.14	3.14E-03	4.02E-02
synaptic membrane adhesion (GO:0099560)	24	11	3.51	+	3.14	3.14E-03	4.02E-02
atrioventricular valve morphogenesis (GO:0003181)	24	11	3.51	+	3.14	3.14E-03	4.02E-02
biological process involved in interspecies interaction between organisms (GO:0044419)	1593	187	232.67	-	.80	3.08E-03	3.95E-02
mammary gland morphogenesis (GO:0060443)	44	16	6.43	+	2.49	3.07E-03	3.94E-02
embryonic axis specification (GO:0000578)	39	15	5.70	+	2.63	3.05E-03	3.93E-02
regulation of striated muscle tissue development (GO:0016202)	39	15	5.70	+	2.63	3.05E-03	3.93E-02
negative regulation of insulin secretion (GO:0046676)	39	15	5.70	+	2.63	3.05E-03	3.93E-02
chondroitin sulfate metabolic process (GO:0030204)	39	15	5.70	+	2.63	3.05E-03	3.92E-02
glial cell fate commitment (GO:0021781)	13	8	1.90	+	4.21	3.00E-03	3.89E-02
ventral spinal cord interneuron differentiation (GO:0021514)	13	8	1.90	+	4.21	3.00E-03	3.88E-02
negative regulation of amino acid transport (GO:0051956)	13	8	1.90	+	4.21	3.00E-03	3.88E-02
regulation of pigmentation (GO:0120305)	13	8	1.90	+	4.21	3.00E-03	3.88E-02
regulation of developmental pigmentation (GO:0048070)	13	8	1.90	+	4.21	3.00E-03	3.87E-02
uterus development (GO:0060065)	20	10	2.92	+	3.42	2.96E-03	3.84E-02
stress response to metal ion (GO:0097501)	20	10	2.92	+	3.42	2.96E-03	3.84E-02
positive regulation of protein secretion (GO:0050714)	138	36	20.16	+	1.79	2.86E-03	3.70E-02
positive regulation of lipid localization (GO:1905954)	107	30	15.63	+	1.92	2.79E-03	3.63E-02
female gonad development (GO:0008585)	88	26	12.85	+	2.02	2.75E-03	3.58E-02
detection of external stimulus (GO:0009581)	137	36	20.01	+	1.80	2.71E-03	3.53E-02
cell-substrate adhesion (GO:0031589)	184	45	26.87	+	1.67	2.71E-03	3.53E-02
positive regulation of heart contraction (GO:0045823)	38	15	5.55	+	2.70	2.70E-03	3.52E-02
negative regulation of developmental growth (GO:0048640)	106	30	15.48	+	1.94	2.66E-03	3.47E-02
actin filament-based process (GO:0030029)	605	120	88.36	+	1.36	2.66E-03	3.47E-02
potassium ion import across plasma membrane (GO:1990573)	43	16	6.28	+	2.55	2.63E-03	3.44E-02
regulation of muscle organ development (GO:0048634)	43	16	6.28	+	2.55	2.63E-03	3.44E-02
lung alveolus development (GO:0048286)	43	16	6.28	+	2.55	2.63E-03	3.43E-02
regulation of cardiac muscle cell differentiation (GO:2000725)	16	9	2.34	+	3.85	2.62E-03	3.43E-02
regulation of norepinephrine secretion (GO:0014061)	16	9	2.34	+	3.85	2.62E-03	3.43E-02
posttranscriptional regulation of gene expression (GO:0010608)	581	57	84.86	-	.67	2.59E-03	3.40E-02
establishment of localization in cell (GO:0051649)	2335	286	341.04	-	.84	2.58E-03	3.38E-02
regulation of mesenchymal cell proliferation (GO:0010464)	31	13	4.53	+	2.87	2.55E-03	3.35E-02
regulation of feeding behavior (GO:0060259)	27	12	3.94	+	3.04	2.53E-03	3.33E-02
immune system development (GO:0002520)	670	131	97.86	+	1.34	2.50E-03	3.29E-02
activation of innate immune response (GO:0002218)	150	8	21.91	-	.37	2.48E-03	3.26E-02
cellular response to ketone (GO:1901655)	95	28	13.88	+	2.02	2.47E-03	3.26E-02
organic cyclic compound catabolic process (GO:1901361)	466	43	68.06	-	.63	2.45E-03	3.24E-02
protein acetylation (GO:0006473)	138	7	20.16	-	.35	2.45E-03	3.23E-02
cellular protein complex disassembly (GO:0043624)	138	7	20.16	-	.35	2.45E-03	3.23E-02
subpallium development (GO:0021544)	23	11	3.36	+	3.27	2.43E-03	3.23E-02
regulation of organic acid transport (GO:0032890)	69	22	10.08	+	2.18	2.44E-03	3.23E-02
cyclic purine nucleotide metabolic process (GO:0052652)	23	11	3.36	+	3.27	2.43E-03	3.22E-02
cyclic nucleotide biosynthetic process (GO:0009190)	23	11	3.36	+	3.27	2.43E-03	3.22E-02
embryonic camera-type eye development (GO:0031076)	37	15	5.40	+	2.78	2.43E-03	3.22E-02
cerebral cortex neuron differentiation (GO:0021895)	23	11	3.36	+	3.27	2.43E-03	3.22E-02
regulation of translational initiation (GO:0006446)	81	2	11.83	-	.17	2.42E-03	3.21E-02
regulation of cellular component biogenesis (GO:0044087)	974	182	142.26	+	1.28	2.41E-03	3.21E-02
positive regulation of neural precursor cell proliferation (GO:2000179)	55	19	8.03	+	2.37	2.39E-03	3.18E-02
ventricular cardiac muscle tissue development (GO:0003229)	55	19	8.03	+	2.37	2.39E-03	3.18E-02
negative regulation of leukocyte differentiation (GO:1902106)	102	29	14.90	+	1.95	2.38E-03	3.17E-02
regulation of ERK1 and ERK2 cascade (GO:0070372)	294	66	42.94	+	1.54	2.36E-03	3.15E-02
positive regulation of striated muscle cell differentiation (GO:0051155)	47	17	6.86	+	2.48	2.35E-03	3.13E-02
response to decreased oxygen levels (GO:0036293)	361	78	52.73	+	1.48	2.33E-03	3.11E-02
membrane organization (GO:0061024)	972	105	141.97	-	.74	2.33E-03	3.11E-02
DNA-templated transcription, elongation (GO:0006354)	79	2	11.54	-	.17	2.28E-03	3.06E-02
regulation of wound healing (GO:0061041)	131	35	19.13	+	1.83	2.27E-03	3.05E-02
phenol-containing compound metabolic process (GO:0018958)	92	27	13.44	+	2.01	2.27E-03	3.05E-02
positive regulation of glial cell differentiation (GO:0045687)	42	16	6.13	+	2.61	2.27E-03	3.04E-02
regulation of phagocytosis (GO:0050764)	92	27	13.44	+	2.01	2.27E-03	3.04E-02
regulation of organ growth (GO:0046620)	92	27	13.44	+	2.01	2.27E-03	3.04E-02
positive regulation of telomere maintenance (GO:0032206)	51	0	7.45	-	 < 0.01	2.24E-03	3.02E-02
detoxification of inorganic compound (GO:0061687)	19	10	2.78	+	3.60	2.23E-03	3.00E-02
negative regulation of bone remodeling (GO:0046851)	19	10	2.78	+	3.60	2.23E-03	3.00E-02
chondrocyte differentiation (GO:0002062)	68	22	9.93	+	2.22	2.21E-03	2.98E-02
regulation of bone mineralization (GO:0030500)	76	24	11.10	+	2.16	2.19E-03	2.96E-02
secretion (GO:0046903)	1047	194	152.92	+	1.27	2.19E-03	2.95E-02
regulation of heart morphogenesis (GO:2000826)	9	7	1.31	+	5.33	2.17E-03	2.93E-02
excitatory chemical synaptic transmission (GO:0098976)	9	7	1.31	+	5.33	2.17E-03	2.93E-02
cyclic-nucleotide-mediated signaling (GO:0019935)	54	19	7.89	+	2.41	2.15E-03	2.92E-02
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)	54	19	7.89	+	2.41	2.15E-03	2.92E-02
regulation of response to biotic stimulus (GO:0002831)	434	39	63.39	-	.62	2.14E-03	2.91E-02
negative regulation of canonical Wnt signaling pathway (GO:0090090)	187	46	27.31	+	1.68	2.14E-03	2.91E-02
negative regulation of platelet aggregation (GO:0090331)	12	8	1.75	+	4.56	2.09E-03	2.85E-02
negative regulation of neuron projection development (GO:0010977)	140	37	20.45	+	1.81	2.10E-03	2.85E-02
negative regulation of protein phosphorylation (GO:0001933)	353	77	51.56	+	1.49	2.09E-03	2.85E-02
midbrain dopaminergic neuron differentiation (GO:1904948)	12	8	1.75	+	4.56	2.09E-03	2.85E-02
inhibitory synapse assembly (GO:1904862)	12	8	1.75	+	4.56	2.09E-03	2.85E-02
cardiac cell fate commitment (GO:0060911)	12	8	1.75	+	4.56	2.09E-03	2.85E-02
telencephalon regionalization (GO:0021978)	12	8	1.75	+	4.56	2.09E-03	2.84E-02
response to oxygen levels (GO:0070482)	388	83	56.67	+	1.46	2.07E-03	2.83E-02
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	49	0	7.16	-	 < 0.01	2.06E-03	2.83E-02
regulation of systemic arterial blood pressure (GO:0003073)	100	29	14.61	+	1.99	2.05E-03	2.81E-02
negative regulation of cell projection organization (GO:0031345)	186	46	27.17	+	1.69	2.05E-03	2.81E-02
Notch signaling pathway (GO:0007219)	119	33	17.38	+	1.90	2.04E-03	2.79E-02
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	30	13	4.38	+	2.97	2.03E-03	2.79E-02
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	30	13	4.38	+	2.97	2.03E-03	2.79E-02
forebrain neuron development (GO:0021884)	30	13	4.38	+	2.97	2.03E-03	2.79E-02
import across plasma membrane (GO:0098739)	139	37	20.30	+	1.82	2.00E-03	2.75E-02
gamma-aminobutyric acid signaling pathway (GO:0007214)	26	12	3.80	+	3.16	1.98E-03	2.75E-02
development of primary male sexual characteristics (GO:0046546)	139	37	20.30	+	1.82	2.00E-03	2.75E-02
pharyngeal system development (GO:0060037)	26	12	3.80	+	3.16	1.98E-03	2.75E-02
regulation of cell size (GO:0008361)	185	46	27.02	+	1.70	1.97E-03	2.75E-02
retina layer formation (GO:0010842)	26	12	3.80	+	3.16	1.98E-03	2.75E-02
negative regulation of anion transport (GO:1903792)	26	12	3.80	+	3.16	1.98E-03	2.74E-02
regulation of myoblast differentiation (GO:0045661)	53	19	7.74	+	2.45	1.97E-03	2.74E-02
cell fate commitment involved in formation of primary germ layer (GO:0060795)	26	12	3.80	+	3.16	1.98E-03	2.74E-02
transmission of nerve impulse (GO:0019226)	53	19	7.74	+	2.45	1.97E-03	2.74E-02
metanephric tubule formation (GO:0072174)	6	6	.88	+	6.85	1.98E-03	2.74E-02
positive regulation of heart rate (GO:0010460)	26	12	3.80	+	3.16	1.98E-03	2.74E-02
sinoatrial node cell differentiation (GO:0060921)	6	6	.88	+	6.85	1.98E-03	2.74E-02
cerebral cortex GABAergic interneuron migration (GO:0021853)	6	6	.88	+	6.85	1.98E-03	2.73E-02
regulation of canonical Wnt signaling pathway (GO:0060828)	298	67	43.52	+	1.54	1.96E-03	2.73E-02
exocrine system development (GO:0035272)	41	16	5.99	+	2.67	1.98E-03	2.73E-02
regulation of anion transport (GO:0044070)	90	27	13.14	+	2.05	1.93E-03	2.70E-02
tRNA modification (GO:0006400)	93	3	13.58	-	.22	1.92E-03	2.69E-02
male gonad development (GO:0008584)	138	37	20.16	+	1.84	1.91E-03	2.68E-02
positive regulation of cell adhesion (GO:0045785)	438	92	63.97	+	1.44	1.91E-03	2.68E-02
positive regulation of endothelial cell migration (GO:0010595)	108	31	15.77	+	1.97	1.91E-03	2.68E-02
cardiac muscle cell differentiation (GO:0055007)	81	25	11.83	+	2.11	1.91E-03	2.67E-02
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	15	9	2.19	+	4.11	1.89E-03	2.66E-02
enteric nervous system development (GO:0048484)	15	9	2.19	+	4.11	1.89E-03	2.65E-02
response to alkaloid (GO:0043279)	117	33	17.09	+	1.93	1.87E-03	2.64E-02
cellular response to prostaglandin stimulus (GO:0071379)	22	11	3.21	+	3.42	1.86E-03	2.62E-02
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	22	11	3.21	+	3.42	1.86E-03	2.62E-02
detection of temperature stimulus involved in sensory perception (GO:0050961)	22	11	3.21	+	3.42	1.86E-03	2.62E-02
regulation of sodium ion transmembrane transport (GO:1902305)	66	22	9.64	+	2.28	1.86E-03	2.62E-02
endocardial cushion formation (GO:0003272)	22	11	3.21	+	3.42	1.86E-03	2.61E-02
defense response to bacterium (GO:0042742)	350	29	51.12	-	.57	1.84E-03	2.60E-02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	269	20	39.29	-	.51	1.81E-03	2.56E-02
postsynapse organization (GO:0099173)	89	27	13.00	+	2.08	1.81E-03	2.56E-02
plasma membrane invagination (GO:0099024)	141	7	20.59	-	.34	1.79E-03	2.54E-02
embryonic epithelial tube formation (GO:0001838)	124	34	18.11	+	1.88	1.76E-03	2.50E-02
endothelium development (GO:0003158)	97	29	14.17	+	2.05	1.76E-03	2.50E-02
positive regulation of blood pressure (GO:0045777)	40	16	5.84	+	2.74	1.75E-03	2.50E-02
regulation of NMDA receptor activity (GO:2000310)	40	16	5.84	+	2.74	1.75E-03	2.49E-02
positive regulation of blood circulation (GO:1903524)	40	16	5.84	+	2.74	1.75E-03	2.49E-02
positive regulation of programmed cell death (GO:0043068)	575	116	83.98	+	1.38	1.74E-03	2.48E-02
regulation of vascular permeability (GO:0043114)	45	17	6.57	+	2.59	1.71E-03	2.44E-02
antigen processing and presentation (GO:0019882)	225	15	32.86	-	.46	1.71E-03	2.43E-02
negative regulation of hemopoiesis (GO:1903707)	104	30	15.19	+	1.98	1.68E-03	2.41E-02
regulation of complement activation (GO:0030449)	118	5	17.23	-	.29	1.68E-03	2.40E-02
cellular biosynthetic process (GO:0044249)	2715	335	396.54	-	.84	1.67E-03	2.39E-02
cGMP metabolic process (GO:0046068)	18	10	2.63	+	3.80	1.64E-03	2.36E-02
specification of animal organ identity (GO:0010092)	18	10	2.63	+	3.80	1.64E-03	2.36E-02
skeletal muscle tissue development (GO:0007519)	123	34	17.96	+	1.89	1.65E-03	2.36E-02
spinal cord patterning (GO:0021511)	18	10	2.63	+	3.80	1.64E-03	2.36E-02
neurotransmitter biosynthetic process (GO:0042136)	18	10	2.63	+	3.80	1.64E-03	2.36E-02
regulation of synaptic transmission, GABAergic (GO:0032228)	33	14	4.82	+	2.90	1.62E-03	2.34E-02
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	184	11	26.87	-	.41	1.63E-03	2.34E-02
regulation of presynapse assembly (GO:1905606)	33	14	4.82	+	2.90	1.62E-03	2.34E-02
regulation of presynapse organization (GO:0099174)	33	14	4.82	+	2.90	1.62E-03	2.34E-02
regulation of homotypic cell-cell adhesion (GO:0034110)	29	13	4.24	+	3.07	1.60E-03	2.32E-02
spinal cord motor neuron differentiation (GO:0021522)	29	13	4.24	+	3.07	1.60E-03	2.32E-02
response to vitamin D (GO:0033280)	29	13	4.24	+	3.07	1.60E-03	2.32E-02
walking behavior (GO:0090659)	29	13	4.24	+	3.07	1.60E-03	2.32E-02
aorta morphogenesis (GO:0035909)	29	13	4.24	+	3.07	1.60E-03	2.31E-02
response to pain (GO:0048265)	29	13	4.24	+	3.07	1.60E-03	2.31E-02
nuclear transport (GO:0051169)	264	19	38.56	-	.49	1.58E-03	2.30E-02
positive regulation of lipid kinase activity (GO:0090218)	39	16	5.70	+	2.81	1.58E-03	2.30E-02
regulation of heart rate by cardiac conduction (GO:0086091)	39	16	5.70	+	2.81	1.58E-03	2.30E-02
nucleocytoplasmic transport (GO:0006913)	261	19	38.12	-	.50	1.55E-03	2.26E-02
endoderm formation (GO:0001706)	49	18	7.16	+	2.52	1.53E-03	2.24E-02
positive regulation of epithelial to mesenchymal transition (GO:0010718)	49	18	7.16	+	2.52	1.53E-03	2.24E-02
secondary palate development (GO:0062009)	25	12	3.65	+	3.29	1.53E-03	2.23E-02
neural precursor cell proliferation (GO:0061351)	70	23	10.22	+	2.25	1.50E-03	2.19E-02
digestive tract morphogenesis (GO:0048546)	44	17	6.43	+	2.65	1.48E-03	2.16E-02
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	44	17	6.43	+	2.65	1.48E-03	2.16E-02
ATP metabolic process (GO:0046034)	206	13	30.09	-	.43	1.47E-03	2.16E-02
regulation of response to wounding (GO:1903034)	162	42	23.66	+	1.78	1.46E-03	2.14E-02
regulation of telomere maintenance via telomerase (GO:0032210)	54	0	7.89	-	 < 0.01	1.46E-03	2.14E-02
anion transmembrane transport (GO:0098656)	224	54	32.72	+	1.65	1.46E-03	2.14E-02
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	111	32	16.21	+	1.97	1.44E-03	2.12E-02
response to cocaine (GO:0042220)	56	20	8.18	+	2.45	1.44E-03	2.12E-02
dendrite development (GO:0016358)	111	32	16.21	+	1.97	1.44E-03	2.12E-02
regulation of protein kinase B signaling (GO:0051896)	235	56	34.32	+	1.63	1.40E-03	2.07E-02
metanephric epithelium development (GO:0072207)	21	11	3.07	+	3.59	1.40E-03	2.07E-02
regulation of collateral sprouting (GO:0048670)	21	11	3.07	+	3.59	1.40E-03	2.07E-02
sympathetic nervous system development (GO:0048485)	21	11	3.07	+	3.59	1.40E-03	2.06E-02
type B pancreatic cell differentiation (GO:0003309)	21	11	3.07	+	3.59	1.40E-03	2.06E-02
regulation of serotonin secretion (GO:0014062)	8	7	1.17	+	5.99	1.37E-03	2.03E-02
interneuron migration (GO:1904936)	8	7	1.17	+	5.99	1.37E-03	2.03E-02
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	8	7	1.17	+	5.99	1.37E-03	2.03E-02
negative regulation of BMP signaling pathway (GO:0030514)	61	21	8.91	+	2.36	1.35E-03	2.01E-02
negative regulation of homotypic cell-cell adhesion (GO:0034111)	14	9	2.04	+	4.40	1.33E-03	1.98E-02
regulation of exocytosis (GO:0017157)	207	51	30.23	+	1.69	1.32E-03	1.97E-02
protein localization to endoplasmic reticulum (GO:0070972)	143	7	20.89	-	.34	1.31E-03	1.95E-02
protein acylation (GO:0043543)	178	10	26.00	-	.38	1.30E-03	1.94E-02
cardiac atrium development (GO:0003230)	36	15	5.26	+	2.85	1.29E-03	1.93E-02
cell communication involved in cardiac conduction (GO:0086065)	43	17	6.28	+	2.71	1.29E-03	1.92E-02
phagocytosis, engulfment (GO:0006911)	132	6	19.28	-	.31	1.27E-03	1.91E-02
RNA export from nucleus (GO:0006405)	124	5	18.11	-	.28	1.26E-03	1.88E-02
behavioral defense response (GO:0002209)	28	13	4.09	+	3.18	1.25E-03	1.87E-02
adult walking behavior (GO:0007628)	28	13	4.09	+	3.18	1.25E-03	1.87E-02
endochondral bone morphogenesis (GO:0060350)	54	20	7.89	+	2.54	1.22E-03	1.83E-02
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	191	48	27.90	+	1.72	1.22E-03	1.83E-02
mitotic sister chromatid segregation (GO:0000070)	121	5	17.67	-	.28	1.21E-03	1.82E-02
negative regulation of behavior (GO:0048521)	17	10	2.48	+	4.03	1.19E-03	1.80E-02
response to hypoxia (GO:0001666)	347	77	50.68	+	1.52	1.19E-03	1.80E-02
positive regulation of voltage-gated potassium channel activity (GO:1903818)	17	10	2.48	+	4.03	1.19E-03	1.80E-02
positive regulation of calcium ion transport (GO:0051928)	125	35	18.26	+	1.92	1.19E-03	1.79E-02
positive regulation of lipid metabolic process (GO:0045834)	155	41	22.64	+	1.81	1.17E-03	1.77E-02
outflow tract septum morphogenesis (GO:0003148)	24	12	3.51	+	3.42	1.17E-03	1.77E-02
opsonization (GO:0008228)	72	1	10.52	-	.10	1.16E-03	1.75E-02
negative regulation of leukocyte migration (GO:0002686)	42	17	6.13	+	2.77	1.14E-03	1.72E-02
regulation of regulated secretory pathway (GO:1903305)	144	39	21.03	+	1.85	1.13E-03	1.71E-02
calcium ion transport into cytosol (GO:0060402)	73	24	10.66	+	2.25	1.13E-03	1.71E-02
mRNA export from nucleus (GO:0006406)	110	4	16.07	-	.25	1.10E-03	1.67E-02
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	110	4	16.07	-	.25	1.10E-03	1.67E-02
biosynthetic process (GO:0009058)	2865	353	418.45	-	.84	1.07E-03	1.63E-02
sprouting angiogenesis (GO:0002040)	59	21	8.62	+	2.44	1.06E-03	1.62E-02
peptide secretion (GO:0002790)	59	21	8.62	+	2.44	1.06E-03	1.62E-02
regulation of steroid hormone secretion (GO:2000831)	20	11	2.92	+	3.77	1.03E-03	1.58E-02
positive regulation of gene expression (GO:0010628)	1169	217	170.74	+	1.27	1.03E-03	1.58E-02
positive regulation of fat cell differentiation (GO:0045600)	64	22	9.35	+	2.35	1.03E-03	1.58E-02
regulation of lipid localization (GO:1905952)	163	43	23.81	+	1.81	1.03E-03	1.58E-02
nitric oxide mediated signal transduction (GO:0007263)	20	11	2.92	+	3.77	1.03E-03	1.58E-02
positive regulation of gliogenesis (GO:0014015)	64	22	9.35	+	2.35	1.03E-03	1.58E-02
positive regulation of chondrocyte differentiation (GO:0032332)	20	11	2.92	+	3.77	1.03E-03	1.58E-02
regulation of biomineralization (GO:0110149)	95	29	13.88	+	2.09	1.02E-03	1.57E-02
neurotransmitter metabolic process (GO:0042133)	31	14	4.53	+	3.09	1.01E-03	1.56E-02
regulation of establishment of protein localization (GO:0070201)	581	119	84.86	+	1.40	1.01E-03	1.55E-02
positive regulation of protein serine/threonine kinase activity (GO:0071902)	321	73	46.88	+	1.56	9.97E-04	1.54E-02
regulation of striated muscle cell differentiation (GO:0051153)	86	27	12.56	+	2.15	9.95E-04	1.54E-02
Golgi vesicle transport (GO:0048193)	398	33	58.13	-	.57	9.85E-04	1.52E-02
negative regulation of inflammatory response (GO:0050728)	320	73	46.74	+	1.56	9.79E-04	1.52E-02
positive regulation of collagen biosynthetic process (GO:0032967)	27	13	3.94	+	3.30	9.63E-04	1.50E-02
behavioral fear response (GO:0001662)	27	13	3.94	+	3.30	9.63E-04	1.50E-02
membrane invagination (GO:0010324)	148	7	21.62	-	.32	9.66E-04	1.50E-02
embryonic camera-type eye morphogenesis (GO:0048596)	27	13	3.94	+	3.30	9.63E-04	1.50E-02
cell-cell signaling involved in cardiac conduction (GO:0086019)	27	13	3.94	+	3.30	9.63E-04	1.50E-02
response to nicotine (GO:0035094)	46	18	6.72	+	2.68	9.59E-04	1.50E-02
detection of temperature stimulus (GO:0016048)	27	13	3.94	+	3.30	9.63E-04	1.49E-02
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	207	52	30.23	+	1.72	9.49E-04	1.48E-02
antigen receptor-mediated signaling pathway (GO:0050851)	299	22	43.67	-	.50	9.45E-04	1.48E-02
embryonic heart tube morphogenesis (GO:0003143)	71	24	10.37	+	2.31	9.28E-04	1.45E-02
positive regulation of steroid hormone secretion (GO:2000833)	10	8	1.46	+	5.48	9.19E-04	1.44E-02
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	10	8	1.46	+	5.48	9.19E-04	1.44E-02
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	10	8	1.46	+	5.48	9.19E-04	1.44E-02
interneuron migration from the subpallium to the cortex (GO:0021830)	10	8	1.46	+	5.48	9.19E-04	1.44E-02
substrate-independent telencephalic tangential migration (GO:0021826)	10	8	1.46	+	5.48	9.19E-04	1.44E-02
mesodermal cell fate commitment (GO:0001710)	13	9	1.90	+	4.74	9.12E-04	1.43E-02
hematopoietic or lymphoid organ development (GO:0048534)	633	128	92.45	+	1.38	8.99E-04	1.42E-02
response to peptide (GO:1901652)	488	103	71.27	+	1.45	9.00E-04	1.42E-02
innervation (GO:0060384)	23	12	3.36	+	3.57	8.78E-04	1.39E-02
cell aggregation (GO:0098743)	23	12	3.36	+	3.57	8.78E-04	1.39E-02
enteroendocrine cell differentiation (GO:0035883)	23	12	3.36	+	3.57	8.78E-04	1.39E-02
male genitalia development (GO:0030539)	23	12	3.36	+	3.57	8.78E-04	1.39E-02
peptide hormone secretion (GO:0030072)	57	21	8.33	+	2.52	8.74E-04	1.38E-02
cardiac ventricle morphogenesis (GO:0003208)	70	24	10.22	+	2.35	8.58E-04	1.36E-02
cellular response to inorganic substance (GO:0071241)	228	56	33.30	+	1.68	8.55E-04	1.36E-02
striated muscle cell differentiation (GO:0051146)	191	49	27.90	+	1.76	8.49E-04	1.35E-02
detoxification of copper ion (GO:0010273)	16	10	2.34	+	4.28	8.46E-04	1.35E-02
stress response to copper ion (GO:1990169)	16	10	2.34	+	4.28	8.46E-04	1.35E-02
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	212	13	30.96	-	.42	8.42E-04	1.34E-02
canonical Wnt signaling pathway (GO:0060070)	84	27	12.27	+	2.20	8.30E-04	1.32E-02
positive regulation of amine transport (GO:0051954)	38	16	5.55	+	2.88	8.27E-04	1.32E-02
anterior/posterior axon guidance (GO:0033564)	7	7	1.02	+	6.85	8.20E-04	1.31E-02
regulation of chemotaxis (GO:0050920)	226	56	33.01	+	1.70	8.13E-04	1.30E-02
aminoglycan metabolic process (GO:0006022)	166	44	24.25	+	1.81	7.98E-04	1.28E-02
regulation of cell cycle G2/M phase transition (GO:1902749)	222	14	32.42	-	.43	7.96E-04	1.28E-02
neurotransmitter uptake (GO:0001504)	30	14	4.38	+	3.20	7.89E-04	1.27E-02
regulation of muscle cell differentiation (GO:0051147)	145	40	21.18	+	1.89	7.85E-04	1.26E-02
endoderm development (GO:0007492)	75	25	10.95	+	2.28	7.63E-04	1.23E-02
positive regulation of stem cell differentiation (GO:2000738)	19	11	2.78	+	3.96	7.53E-04	1.21E-02
skeletal muscle organ development (GO:0060538)	134	38	19.57	+	1.94	7.52E-04	1.21E-02
meiotic cell cycle (GO:0051321)	233	15	34.03	-	.44	7.50E-04	1.21E-02
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	44	18	6.43	+	2.80	7.38E-04	1.19E-02
developmental induction (GO:0031128)	26	13	3.80	+	3.42	7.35E-04	1.19E-02
protein localization to organelle (GO:0033365)	742	73	108.37	-	.67	7.37E-04	1.19E-02
regulation of collagen metabolic process (GO:0010712)	44	18	6.43	+	2.80	7.38E-04	1.19E-02
axis elongation (GO:0003401)	26	13	3.80	+	3.42	7.35E-04	1.19E-02
mitotic spindle organization (GO:0007052)	163	8	23.81	-	.34	7.31E-04	1.19E-02
regulation of Notch signaling pathway (GO:0008593)	106	32	15.48	+	2.07	7.25E-04	1.18E-02
response to amine (GO:0014075)	49	19	7.16	+	2.65	7.25E-04	1.18E-02
response to biotic stimulus (GO:0009607)	1547	175	225.95	-	.77	7.22E-04	1.17E-02
RNA modification (GO:0009451)	172	9	25.12	-	.36	7.14E-04	1.16E-02
nucleobase-containing compound transport (GO:0015931)	245	16	35.78	-	.45	7.12E-04	1.16E-02
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	258	62	37.68	+	1.65	6.91E-04	1.13E-02
positive regulation of epithelial cell migration (GO:0010634)	150	41	21.91	+	1.87	6.69E-04	1.09E-02
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	140	39	20.45	+	1.91	6.65E-04	1.09E-02
positive regulation of muscle contraction (GO:0045933)	43	18	6.28	+	2.87	6.66E-04	1.09E-02
neural crest cell migration (GO:0001755)	53	20	7.74	+	2.58	6.55E-04	1.08E-02
response to nutrient (GO:0007584)	170	45	24.83	+	1.81	6.54E-04	1.07E-02
anterior/posterior axis specification (GO:0009948)	53	20	7.74	+	2.58	6.55E-04	1.07E-02
cartilage condensation (GO:0001502)	22	12	3.21	+	3.73	6.52E-04	1.07E-02
neural crest cell development (GO:0014032)	79	26	11.54	+	2.25	6.50E-04	1.07E-02
response to amphetamine (GO:0001975)	33	15	4.82	+	3.11	6.43E-04	1.06E-02
proximal/distal pattern formation (GO:0009954)	33	15	4.82	+	3.11	6.43E-04	1.06E-02
anion transport (GO:0006820)	460	99	67.19	+	1.47	6.44E-04	1.06E-02
extracellular matrix assembly (GO:0085029)	33	15	4.82	+	3.11	6.43E-04	1.06E-02
aromatic compound catabolic process (GO:0019439)	438	37	63.97	-	.58	6.38E-04	1.06E-02
positive regulation of cell death (GO:0010942)	638	130	93.18	+	1.40	6.34E-04	1.05E-02
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	48	19	7.01	+	2.71	6.23E-04	1.03E-02
nuclear chromosome segregation (GO:0098813)	227	14	33.15	-	.42	6.12E-04	1.02E-02
osteoblast differentiation (GO:0001649)	129	37	18.84	+	1.96	6.10E-04	1.01E-02
cardiac atrium morphogenesis (GO:0003209)	29	14	4.24	+	3.31	6.09E-04	1.01E-02
heart looping (GO:0001947)	65	23	9.49	+	2.42	5.99E-04	9.97E-03
MAPK cascade (GO:0000165)	402	89	58.71	+	1.52	5.96E-04	9.93E-03
circadian rhythm (GO:0007623)	138	39	20.16	+	1.93	5.92E-04	9.89E-03
muscle cell fate commitment (GO:0042693)	15	10	2.19	+	4.56	5.87E-04	9.81E-03
memory (GO:0007613)	119	35	17.38	+	2.01	5.84E-04	9.77E-03
positive regulation of protein tyrosine kinase activity (GO:0061098)	59	22	8.62	+	2.55	5.82E-04	9.74E-03
cellular protein modification process (GO:0006464)	2985	366	435.97	-	.84	5.79E-04	9.71E-03
protein modification process (GO:0036211)	2985	366	435.97	-	.84	5.79E-04	9.70E-03
tube formation (GO:0035148)	147	41	21.47	+	1.91	5.72E-04	9.63E-03
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	147	41	21.47	+	1.91	5.72E-04	9.62E-03
peptidyl-tyrosine modification (GO:0018212)	156	43	22.78	+	1.89	5.51E-04	9.28E-03
negative regulation of cellular response to growth factor stimulus (GO:0090288)	109	33	15.92	+	2.07	5.45E-04	9.18E-03
negative regulation of chromosome organization (GO:2001251)	79	1	11.54	-	.09	5.43E-04	9.16E-03
positive regulation of cAMP-mediated signaling (GO:0043950)	18	11	2.63	+	4.18	5.39E-04	9.09E-03
response to nutrient levels (GO:0031667)	501	107	73.17	+	1.46	5.36E-04	9.05E-03
antigen processing and presentation of exogenous antigen (GO:0019884)	186	10	27.17	-	.37	5.24E-04	8.87E-03
viral process (GO:0016032)	444	37	64.85	-	.57	5.22E-04	8.85E-03
response to calcium ion (GO:0051592)	153	42	22.35	+	1.88	5.18E-04	8.84E-03
regulation of postsynapse organization (GO:0099175)	91	29	13.29	+	2.18	5.19E-04	8.84E-03
detection of mechanical stimulus involved in sensory perception (GO:0050974)	36	16	5.26	+	3.04	5.21E-04	8.84E-03
peptidyl-tyrosine phosphorylation (GO:0018108)	153	42	22.35	+	1.88	5.18E-04	8.84E-03
regulation of neurotransmitter secretion (GO:0046928)	91	29	13.29	+	2.18	5.19E-04	8.83E-03
regulation of platelet activation (GO:0010543)	36	16	5.26	+	3.04	5.21E-04	8.83E-03
regulation of epithelial to mesenchymal transition (GO:0010717)	91	29	13.29	+	2.18	5.19E-04	8.82E-03
lymphocyte mediated immunity (GO:0002449)	259	17	37.83	-	.45	5.10E-04	8.72E-03
regulation of lipid transport (GO:0032368)	133	38	19.43	+	1.96	5.00E-04	8.56E-03
regulation of kidney development (GO:0090183)	32	15	4.67	+	3.21	5.00E-04	8.56E-03
stem cell development (GO:0048864)	84	28	12.27	+	2.28	4.99E-04	8.55E-03
positive regulation of MAP kinase activity (GO:0043406)	232	58	33.88	+	1.71	4.98E-04	8.55E-03
regulation of cell-cell adhesion (GO:0022407)	439	96	64.12	+	1.50	4.88E-04	8.38E-03
glycosaminoglycan metabolic process (GO:0030203)	152	42	22.20	+	1.89	4.85E-04	8.35E-03
genitalia development (GO:0048806)	46	19	6.72	+	2.83	4.79E-04	8.27E-03
axonal fasciculation (GO:0007413)	21	12	3.07	+	3.91	4.77E-04	8.27E-03
embryonic cranial skeleton morphogenesis (GO:0048701)	46	19	6.72	+	2.83	4.79E-04	8.26E-03
protein polyubiquitination (GO:0000209)	325	24	47.47	-	.51	4.80E-04	8.26E-03
regulation of platelet aggregation (GO:0090330)	21	12	3.07	+	3.91	4.77E-04	8.26E-03
negative chemotaxis (GO:0050919)	46	19	6.72	+	2.83	4.79E-04	8.26E-03
neuron projection fasciculation (GO:0106030)	21	12	3.07	+	3.91	4.77E-04	8.25E-03
cranial nerve development (GO:0021545)	51	20	7.45	+	2.68	4.72E-04	8.19E-03
sensory perception of temperature stimulus (GO:0050951)	28	14	4.09	+	3.42	4.65E-04	8.09E-03
epithelial tube formation (GO:0072175)	132	38	19.28	+	1.97	4.65E-04	8.08E-03
positive regulation of collagen metabolic process (GO:0010714)	28	14	4.09	+	3.42	4.65E-04	8.08E-03
tRNA processing (GO:0008033)	134	5	19.57	-	.26	4.63E-04	8.07E-03
heterocycle catabolic process (GO:0046700)	417	34	60.90	-	.56	4.58E-04	7.98E-03
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	338	25	49.37	-	.51	4.47E-04	7.80E-03
positive regulation of angiogenesis (GO:0045766)	160	44	23.37	+	1.88	4.36E-04	7.63E-03
positive regulation of vasculature development (GO:1904018)	160	44	23.37	+	1.88	4.36E-04	7.63E-03
glandular epithelial cell differentiation (GO:0002067)	45	19	6.57	+	2.89	4.32E-04	7.59E-03
negative regulation of peptide secretion (GO:0002792)	45	19	6.57	+	2.89	4.32E-04	7.58E-03
midbrain development (GO:0030901)	89	29	13.00	+	2.23	4.25E-04	7.47E-03
regulation of potassium ion transmembrane transporter activity (GO:1901016)	62	23	9.06	+	2.54	4.22E-04	7.43E-03
cellular nitrogen compound biosynthetic process (GO:0044271)	1553	174	226.82	-	.77	4.22E-04	7.43E-03
regulation of protein transport (GO:0051223)	556	117	81.21	+	1.44	4.21E-04	7.42E-03
regulation of collagen biosynthetic process (GO:0032965)	39	17	5.70	+	2.98	4.20E-04	7.42E-03
regulation of extent of cell growth (GO:0061387)	112	34	16.36	+	2.08	4.12E-04	7.27E-03
endocardial cushion morphogenesis (GO:0003203)	35	16	5.11	+	3.13	4.08E-04	7.22E-03
regulation of chromosome organization (GO:0033044)	290	20	42.36	-	.47	4.08E-04	7.22E-03
response to ketone (GO:1901654)	200	52	29.21	+	1.78	3.99E-04	7.08E-03
renal vesicle development (GO:0072087)	14	10	2.04	+	4.89	3.98E-04	7.05E-03
establishment of RNA localization (GO:0051236)	191	10	27.90	-	.36	3.96E-04	7.03E-03
regulation of glial cell differentiation (GO:0045685)	74	26	10.81	+	2.41	3.94E-04	7.01E-03
response to vitamin (GO:0033273)	88	29	12.85	+	2.26	3.91E-04	6.97E-03
metanephric renal vesicle morphogenesis (GO:0072283)	11	9	1.61	+	5.60	3.91E-04	6.97E-03
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	11	9	1.61	+	5.60	3.91E-04	6.96E-03
oxidative phosphorylation (GO:0006119)	120	4	17.53	-	.23	3.88E-04	6.96E-03
RNA transport (GO:0050658)	189	10	27.60	-	.36	3.89E-04	6.96E-03
nucleic acid transport (GO:0050657)	189	10	27.60	-	.36	3.89E-04	6.95E-03
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	178	9	26.00	-	.35	3.89E-04	6.95E-03
fear response (GO:0042596)	31	15	4.53	+	3.31	3.85E-04	6.92E-03
regulation of telomere maintenance via telomere lengthening (GO:1904356)	62	0	9.06	-	 < 0.01	3.83E-04	6.88E-03
ribosome assembly (GO:0042255)	62	0	9.06	-	 < 0.01	3.83E-04	6.87E-03
retinal ganglion cell axon guidance (GO:0031290)	17	11	2.48	+	4.43	3.77E-04	6.80E-03
spindle organization (GO:0007051)	224	13	32.72	-	.40	3.73E-04	6.72E-03
positive regulation of growth (GO:0045927)	257	63	37.54	+	1.68	3.72E-04	6.72E-03
cellular nitrogen compound catabolic process (GO:0044270)	423	34	61.78	-	.55	3.72E-04	6.72E-03
morphogenesis of embryonic epithelium (GO:0016331)	145	41	21.18	+	1.94	3.68E-04	6.66E-03
organic substance biosynthetic process (GO:1901576)	2803	339	409.39	-	.83	3.64E-04	6.59E-03
regulation of epithelial cell proliferation (GO:0050678)	340	79	49.66	+	1.59	3.61E-04	6.54E-03
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	96	2	14.02	-	.14	3.58E-04	6.49E-03
development of primary female sexual characteristics (GO:0046545)	93	30	13.58	+	2.21	3.55E-04	6.45E-03
regulation of protein localization (GO:0032880)	894	176	130.57	+	1.35	3.53E-04	6.42E-03
startle response (GO:0001964)	27	14	3.94	+	3.55	3.50E-04	6.41E-03
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	27	14	3.94	+	3.55	3.50E-04	6.40E-03
detection of stimulus involved in sensory perception of pain (GO:0062149)	27	14	3.94	+	3.55	3.50E-04	6.40E-03
cell maturation (GO:0048469)	154	43	22.49	+	1.91	3.51E-04	6.39E-03
embryonic hindlimb morphogenesis (GO:0035116)	27	14	3.94	+	3.55	3.50E-04	6.39E-03
negative regulation of immune system process (GO:0002683)	597	125	87.19	+	1.43	3.42E-04	6.26E-03
determination of left/right symmetry (GO:0007368)	125	37	18.26	+	2.03	3.38E-04	6.19E-03
regulation of receptor internalization (GO:0002090)	58	22	8.47	+	2.60	3.32E-04	6.09E-03
immune system process (GO:0002376)	2903	352	424.00	-	.83	3.22E-04	5.92E-03
action potential (GO:0001508)	92	30	13.44	+	2.23	3.20E-04	5.89E-03
BMP signaling pathway (GO:0030509)	78	27	11.39	+	2.37	3.14E-04	5.79E-03
developmental growth involved in morphogenesis (GO:0060560)	115	35	16.80	+	2.08	3.13E-04	5.77E-03
negative regulation of hormone secretion (GO:0046888)	65	24	9.49	+	2.53	3.11E-04	5.74E-03
positive regulation of neuron projection development (GO:0010976)	161	45	23.51	+	1.91	3.06E-04	5.67E-03
regulation of protein serine/threonine kinase activity (GO:0071900)	493	107	72.01	+	1.49	3.07E-04	5.67E-03
forebrain regionalization (GO:0021871)	23	13	3.36	+	3.87	3.02E-04	5.62E-03
determination of heart left/right asymmetry (GO:0061371)	70	25	10.22	+	2.45	3.03E-04	5.61E-03
hypothalamus development (GO:0021854)	23	13	3.36	+	3.87	3.02E-04	5.61E-03
response to ethanol (GO:0045471)	141	41	20.59	+	1.99	2.96E-04	5.50E-03
antigen processing and presentation of peptide antigen (GO:0048002)	193	10	28.19	-	.35	2.88E-04	5.37E-03
gliogenesis (GO:0042063)	223	57	32.57	+	1.75	2.88E-04	5.37E-03
ribonucleoprotein complex export from nucleus (GO:0071426)	126	4	18.40	-	.22	2.86E-04	5.33E-03
negative regulation of cell growth (GO:0030308)	190	51	27.75	+	1.84	2.85E-04	5.33E-03
excitatory postsynaptic potential (GO:0060079)	64	24	9.35	+	2.57	2.80E-04	5.24E-03
cellular response to metal ion (GO:0071248)	200	53	29.21	+	1.81	2.76E-04	5.18E-03
protein ubiquitination (GO:0016567)	746	71	108.96	-	.65	2.72E-04	5.11E-03
regulation of neural precursor cell proliferation (GO:2000177)	90	30	13.14	+	2.28	2.68E-04	5.03E-03
aerobic respiration (GO:0009060)	160	7	23.37	-	.30	2.67E-04	5.03E-03
regulation of tissue remodeling (GO:0034103)	76	27	11.10	+	2.43	2.67E-04	5.02E-03
nucleobase-containing compound catabolic process (GO:0034655)	373	28	54.48	-	.51	2.67E-04	5.02E-03
regulation of MAP kinase activity (GO:0043405)	310	74	45.28	+	1.63	2.65E-04	5.00E-03
oligodendrocyte differentiation (GO:0048709)	69	25	10.08	+	2.48	2.64E-04	4.99E-03
positive regulation of transporter activity (GO:0032411)	121	37	17.67	+	2.09	2.64E-04	4.99E-03
glomerulus development (GO:0032835)	52	21	7.59	+	2.77	2.63E-04	4.99E-03
cranial skeletal system development (GO:1904888)	69	25	10.08	+	2.48	2.64E-04	4.99E-03
cochlea development (GO:0090102)	52	21	7.59	+	2.77	2.63E-04	4.98E-03
NADH dehydrogenase complex assembly (GO:0010257)	66	0	9.64	-	 < 0.01	2.61E-04	4.98E-03
mitochondrial respiratory chain complex I assembly (GO:0032981)	66	0	9.64	-	 < 0.01	2.61E-04	4.97E-03
renal vesicle morphogenesis (GO:0072077)	13	10	1.90	+	5.27	2.62E-04	4.97E-03
regulation of animal organ formation (GO:0003156)	26	14	3.80	+	3.69	2.61E-04	4.97E-03
regulation of endocrine process (GO:0044060)	37	17	5.40	+	3.15	2.60E-04	4.96E-03
regulation of vasoconstriction (GO:0019229)	63	24	9.20	+	2.61	2.57E-04	4.92E-03
response to mechanical stimulus (GO:0009612)	220	57	32.13	+	1.77	2.55E-04	4.89E-03
neural crest cell differentiation (GO:0014033)	89	30	13.00	+	2.31	2.50E-04	4.79E-03
sister chromatid segregation (GO:0000819)	149	6	21.76	-	.28	2.49E-04	4.78E-03
regulation of sodium ion transport (GO:0002028)	89	30	13.00	+	2.31	2.50E-04	4.78E-03
negative regulation of platelet activation (GO:0010544)	19	12	2.78	+	4.32	2.42E-04	4.66E-03
growth (GO:0040007)	361	84	52.73	+	1.59	2.33E-04	4.49E-03
regulation of morphogenesis of a branching structure (GO:0060688)	51	21	7.45	+	2.82	2.28E-04	4.40E-03
gonad development (GO:0008406)	215	56	31.40	+	1.78	2.24E-04	4.32E-03
protein targeting to ER (GO:0045047)	112	3	16.36	-	.18	2.23E-04	4.30E-03
response to estradiol (GO:0032355)	144	42	21.03	+	2.00	2.22E-04	4.29E-03
positive regulation of cell junction assembly (GO:1901890)	102	33	14.90	+	2.22	2.20E-04	4.26E-03
negative regulation of blood pressure (GO:0045776)	44	19	6.43	+	2.96	2.17E-04	4.21E-03
negative regulation of peptide hormone secretion (GO:0090278)	44	19	6.43	+	2.96	2.17E-04	4.21E-03
embryonic heart tube development (GO:0035050)	80	28	11.68	+	2.40	2.12E-04	4.12E-03
regulation of endothelial cell migration (GO:0010594)	170	47	24.83	+	1.89	2.11E-04	4.11E-03
establishment of protein localization (GO:0045184)	1397	151	204.04	-	.74	2.06E-04	4.01E-03
nuclear export (GO:0051168)	166	7	24.25	-	.29	2.03E-04	3.95E-03
smooth muscle cell differentiation (GO:0051145)	36	17	5.26	+	3.23	2.02E-04	3.94E-03
in utero embryonic development (GO:0001701)	366	85	53.46	+	1.59	1.96E-04	3.83E-03
positive regulation of peptide hormone secretion (GO:0090277)	107	34	15.63	+	2.18	1.94E-04	3.80E-03
RNA phosphodiester bond hydrolysis (GO:0090501)	164	7	23.95	-	.29	1.94E-04	3.80E-03
cardiocyte differentiation (GO:0035051)	107	34	15.63	+	2.18	1.94E-04	3.80E-03
cellular response to organonitrogen compound (GO:0071417)	604	128	88.22	+	1.45	1.93E-04	3.79E-03
ribonucleoprotein complex localization (GO:0071166)	127	4	18.55	-	.22	1.92E-04	3.78E-03
positive regulation of response to stimulus (GO:0048584)	2312	409	337.68	+	1.21	1.91E-04	3.76E-03
rhythmic process (GO:0048511)	269	67	39.29	+	1.71	1.88E-04	3.72E-03
positive regulation of cartilage development (GO:0061036)	32	16	4.67	+	3.42	1.87E-04	3.69E-03
response to wounding (GO:0009611)	543	117	79.31	+	1.48	1.85E-04	3.65E-03
regulation of neuronal synaptic plasticity (GO:0048168)	49	21	7.16	+	2.93	1.83E-04	3.62E-03
determination of bilateral symmetry (GO:0009855)	130	39	18.99	+	2.05	1.82E-04	3.61E-03
telencephalon cell migration (GO:0022029)	59	23	8.62	+	2.67	1.82E-04	3.61E-03
cardiac muscle tissue morphogenesis (GO:0055008)	59	23	8.62	+	2.67	1.82E-04	3.60E-03
mesenchymal cell development (GO:0014031)	84	29	12.27	+	2.36	1.77E-04	3.52E-03
DNA conformation change (GO:0071103)	312	21	45.57	-	.46	1.77E-04	3.52E-03
positive regulation of axonogenesis (GO:0050772)	84	29	12.27	+	2.36	1.77E-04	3.52E-03
recombinational repair (GO:0000725)	103	2	15.04	-	.13	1.71E-04	3.42E-03
cell differentiation involved in metanephros development (GO:0072202)	18	12	2.63	+	4.56	1.68E-04	3.36E-03
spinal cord association neuron differentiation (GO:0021527)	12	10	1.75	+	5.71	1.67E-04	3.35E-03
anatomical structure maturation (GO:0071695)	196	53	28.63	+	1.85	1.67E-04	3.35E-03
developmental growth (GO:0048589)	358	84	52.29	+	1.61	1.67E-04	3.35E-03
regulation of osteoblast differentiation (GO:0045667)	120	37	17.53	+	2.11	1.66E-04	3.34E-03
negative regulation of Notch signaling pathway (GO:0045746)	39	18	5.70	+	3.16	1.65E-04	3.33E-03
cotranslational protein targeting to membrane (GO:0006613)	101	2	14.75	-	.14	1.64E-04	3.31E-03
double-strand break repair via homologous recombination (GO:0000724)	101	2	14.75	-	.14	1.64E-04	3.30E-03
regulation of neurotransmitter transport (GO:0051588)	105	34	15.34	+	2.22	1.63E-04	3.30E-03
RNA localization (GO:0006403)	212	11	30.96	-	.36	1.61E-04	3.26E-03
mitochondrial translational elongation (GO:0070125)	88	1	12.85	-	.08	1.61E-04	3.26E-03
aerobic electron transport chain (GO:0019646)	88	1	12.85	-	.08	1.61E-04	3.25E-03
mitotic nuclear division (GO:0140014)	201	10	29.36	-	.34	1.59E-04	3.24E-03
cellular response to nitrogen compound (GO:1901699)	664	139	96.98	+	1.43	1.57E-04	3.19E-03
embryonic eye morphogenesis (GO:0048048)	35	17	5.11	+	3.33	1.55E-04	3.17E-03
regulation of fat cell differentiation (GO:0045598)	128	39	18.70	+	2.09	1.55E-04	3.17E-03
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	21	13	3.07	+	4.24	1.55E-04	3.17E-03
epithelial to mesenchymal transition (GO:0001837)	75	27	10.95	+	2.46	1.54E-04	3.16E-03
establishment of protein localization to endoplasmic reticulum (GO:0072599)	116	3	16.94	-	.18	1.54E-04	3.16E-03
female pregnancy (GO:0007565)	182	50	26.58	+	1.88	1.54E-04	3.15E-03
ventricular septum development (GO:0003281)	70	26	10.22	+	2.54	1.53E-04	3.15E-03
positive regulation of ion transmembrane transporter activity (GO:0032414)	110	35	16.07	+	2.18	1.47E-04	3.03E-03
odontogenesis of dentin-containing tooth (GO:0042475)	82	29	11.98	+	2.42	1.43E-04	2.93E-03
forebrain cell migration (GO:0021885)	62	24	9.06	+	2.65	1.41E-04	2.91E-03
adrenergic receptor signaling pathway (GO:0071875)	24	14	3.51	+	3.99	1.39E-04	2.88E-03
regulation of bone resorption (GO:0045124)	46	20	6.72	+	2.98	1.39E-04	2.87E-03
regulation of cAMP-mediated signaling (GO:0043949)	42	19	6.13	+	3.10	1.35E-04	2.80E-03
cellular response to calcium ion (GO:0071277)	87	30	12.71	+	2.36	1.34E-04	2.78E-03
multi-multicellular organism process (GO:0044706)	210	56	30.67	+	1.83	1.33E-04	2.75E-03
G protein-coupled receptor signaling pathway (GO:0007186)	1305	248	190.60	+	1.30	1.31E-04	2.73E-03
regulation of chondrocyte differentiation (GO:0032330)	52	22	7.59	+	2.90	1.31E-04	2.73E-03
embryonic placenta development (GO:0001892)	81	29	11.83	+	2.45	1.31E-04	2.72E-03
regulation of catalytic activity (GO:0050790)	2433	430	355.35	+	1.21	1.29E-04	2.69E-03
proteolysis (GO:0006508)	1306	138	190.75	-	.72	1.26E-04	2.63E-03
response to extracellular stimulus (GO:0009991)	531	116	77.56	+	1.50	1.24E-04	2.60E-03
negative regulation of amine transport (GO:0051953)	27	15	3.94	+	3.80	1.22E-04	2.56E-03
ionotropic glutamate receptor signaling pathway (GO:0035235)	27	15	3.94	+	3.80	1.22E-04	2.56E-03
regulation of epithelial cell migration (GO:0010632)	229	60	33.45	+	1.79	1.20E-04	2.51E-03
hindlimb morphogenesis (GO:0035137)	34	17	4.97	+	3.42	1.18E-04	2.49E-03
specification of symmetry (GO:0009799)	131	40	19.13	+	2.09	1.17E-04	2.47E-03
hormone secretion (GO:0046879)	73	27	10.66	+	2.53	1.16E-04	2.44E-03
negative regulation of ion transport (GO:0043271)	148	44	21.62	+	2.04	1.14E-04	2.41E-03
ureter development (GO:0072189)	17	12	2.48	+	4.83	1.14E-04	2.41E-03
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	67	26	9.79	+	2.66	1.14E-04	2.41E-03
nephron tubule formation (GO:0072079)	17	12	2.48	+	4.83	1.14E-04	2.41E-03
GABAergic neuron differentiation (GO:0097154)	14	11	2.04	+	5.38	1.13E-04	2.40E-03
regulation of heart rate (GO:0002027)	99	33	14.46	+	2.28	1.12E-04	2.39E-03
positive regulation of epithelial cell proliferation (GO:0050679)	194	53	28.33	+	1.87	1.12E-04	2.38E-03
positive regulation of smooth muscle contraction (GO:0045987)	30	16	4.38	+	3.65	1.05E-04	2.25E-03
semi-lunar valve development (GO:1905314)	41	19	5.99	+	3.17	1.06E-04	2.25E-03
myelination (GO:0042552)	106	35	15.48	+	2.26	1.05E-04	2.25E-03
cyclic nucleotide metabolic process (GO:0009187)	41	19	5.99	+	3.17	1.06E-04	2.25E-03
glial cell differentiation (GO:0010001)	173	49	25.27	+	1.94	1.03E-04	2.21E-03
mitochondrial translational termination (GO:0070126)	89	1	13.00	-	.08	1.03E-04	2.20E-03
positive regulation of protein metabolic process (GO:0051247)	1562	291	228.14	+	1.28	1.02E-04	2.19E-03
regulation of gliogenesis (GO:0014013)	98	33	14.31	+	2.31	1.01E-04	2.18E-03
heart valve morphogenesis (GO:0003179)	55	23	8.03	+	2.86	9.63E-05	2.07E-03
mRNA transport (GO:0051028)	160	6	23.37	-	.26	9.21E-05	1.99E-03
calcium ion transmembrane transport (GO:0070588)	190	53	27.75	+	1.91	9.14E-05	1.98E-03
second-messenger-mediated signaling (GO:0019932)	221	59	32.28	+	1.83	9.15E-05	1.98E-03
negative regulation of neurogenesis (GO:0050768)	143	43	20.89	+	2.06	8.98E-05	1.95E-03
male sex differentiation (GO:0046661)	161	47	23.51	+	2.00	8.98E-05	1.95E-03
regulation of neuron apoptotic process (GO:0043523)	210	57	30.67	+	1.86	8.98E-05	1.94E-03
mesodermal cell differentiation (GO:0048333)	26	15	3.80	+	3.95	8.90E-05	1.93E-03
hormone transport (GO:0009914)	83	30	12.12	+	2.47	8.81E-05	1.92E-03
muscle system process (GO:0003012)	288	72	42.06	+	1.71	8.70E-05	1.90E-03
protein-containing complex disassembly (GO:0032984)	228	12	33.30	-	.36	8.64E-05	1.89E-03
endocardial cushion development (GO:0003197)	44	20	6.43	+	3.11	8.64E-05	1.89E-03
hindbrain development (GO:0030902)	151	45	22.05	+	2.04	8.54E-05	1.87E-03
respiratory tube development (GO:0030323)	177	50	25.85	+	1.93	8.50E-05	1.86E-03
negative regulation of secretion by cell (GO:1903531)	142	43	20.74	+	2.07	8.41E-05	1.85E-03
positive regulation of synapse assembly (GO:0051965)	59	24	8.62	+	2.79	8.42E-05	1.85E-03
positive regulation of peptide secretion (GO:0002793)	110	36	16.07	+	2.24	8.39E-05	1.85E-03
mammary gland epithelium development (GO:0061180)	59	24	8.62	+	2.79	8.42E-05	1.85E-03
protein targeting (GO:0006605)	322	21	47.03	-	.45	8.05E-05	1.78E-03
sodium ion transport (GO:0006814)	176	50	25.71	+	1.95	7.91E-05	1.75E-03
proteasomal protein catabolic process (GO:0010498)	361	25	52.73	-	.47	7.85E-05	1.74E-03
aorta development (GO:0035904)	53	23	7.74	+	2.97	7.74E-05	1.72E-03
regulation of bone remodeling (GO:0046850)	53	23	7.74	+	2.97	7.74E-05	1.72E-03
regulation of dopamine secretion (GO:0014059)	36	18	5.26	+	3.42	7.54E-05	1.68E-03
mesenchymal to epithelial transition (GO:0060231)	16	12	2.34	+	5.14	7.55E-05	1.68E-03
ensheathment of neurons (GO:0007272)	108	36	15.77	+	2.28	7.28E-05	1.63E-03
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	492	39	71.86	-	.54	7.30E-05	1.63E-03
axon ensheathment (GO:0008366)	108	36	15.77	+	2.28	7.28E-05	1.63E-03
developmental maturation (GO:0021700)	235	62	34.32	+	1.81	7.28E-05	1.63E-03
regulation of body fluid levels (GO:0050878)	494	111	72.15	+	1.54	7.18E-05	1.61E-03
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	93	1	13.58	-	.07	6.92E-05	1.56E-03
ATP synthesis coupled electron transport (GO:0042773)	93	1	13.58	-	.07	6.92E-05	1.55E-03
gland morphogenesis (GO:0022612)	100	34	14.61	+	2.33	6.89E-05	1.55E-03
amide biosynthetic process (GO:0043604)	537	44	78.43	-	.56	6.85E-05	1.55E-03
regulation of intracellular signal transduction (GO:1902531)	1839	338	268.59	+	1.26	6.76E-05	1.53E-03
aortic valve morphogenesis (GO:0003180)	32	17	4.67	+	3.64	6.70E-05	1.52E-03
regulation of cell junction assembly (GO:1901888)	202	56	29.50	+	1.90	6.70E-05	1.52E-03
epithelial cell development (GO:0002064)	202	56	29.50	+	1.90	6.70E-05	1.52E-03
lung development (GO:0030324)	173	50	25.27	+	1.98	6.71E-05	1.52E-03
somitogenesis (GO:0001756)	62	25	9.06	+	2.76	6.47E-05	1.47E-03
establishment of protein localization to organelle (GO:0072594)	394	28	57.55	-	.49	6.25E-05	1.42E-03
reproductive process (GO:0022414)	1459	276	213.09	+	1.30	6.20E-05	1.41E-03
regulation of muscle system process (GO:0090257)	231	62	33.74	+	1.84	6.18E-05	1.41E-03
response to abiotic stimulus (GO:0009628)	1175	229	171.61	+	1.33	6.11E-05	1.40E-03
protein transport (GO:0015031)	1300	135	189.87	-	.71	6.08E-05	1.39E-03
sinoatrial node development (GO:0003163)	10	10	1.46	+	6.85	6.08E-05	1.39E-03
muscle contraction (GO:0006936)	241	64	35.20	+	1.82	5.99E-05	1.38E-03
proteoglycan metabolic process (GO:0006029)	85	31	12.41	+	2.50	5.94E-05	1.37E-03
placenta development (GO:0001890)	144	44	21.03	+	2.09	5.95E-05	1.37E-03
cardiac conduction (GO:0061337)	85	31	12.41	+	2.50	5.94E-05	1.37E-03
immune response-regulating signaling pathway (GO:0002764)	495	39	72.30	-	.54	5.82E-05	1.34E-03
regulation of cardiocyte differentiation (GO:1905207)	28	16	4.09	+	3.91	5.68E-05	1.32E-03
cellular respiration (GO:0045333)	187	8	27.31	-	.29	5.65E-05	1.31E-03
retina morphogenesis in camera-type eye (GO:0060042)	61	25	8.91	+	2.81	5.47E-05	1.27E-03
regulation of behavior (GO:0050795)	72	28	10.52	+	2.66	5.42E-05	1.26E-03
translational elongation (GO:0006414)	127	3	18.55	-	.16	5.25E-05	1.22E-03
humoral immune response (GO:0006959)	386	27	56.38	-	.48	5.23E-05	1.22E-03
import into cell (GO:0098657)	176	51	25.71	+	1.98	5.07E-05	1.18E-03
organelle assembly (GO:0070925)	796	73	116.26	-	.63	5.02E-05	1.17E-03
organonitrogen compound metabolic process (GO:1901564)	5246	664	766.20	-	.87	4.99E-05	1.17E-03
cellular component biogenesis (GO:0044085)	2754	323	402.24	-	.80	4.87E-05	1.14E-03
metanephric nephron morphogenesis (GO:0072273)	21	14	3.07	+	4.56	4.85E-05	1.14E-03
translational termination (GO:0006415)	97	1	14.17	-	.07	4.75E-05	1.12E-03
protein-DNA complex assembly (GO:0065004)	256	14	37.39	-	.37	4.69E-05	1.10E-03
development of primary sexual characteristics (GO:0045137)	221	60	32.28	+	1.86	4.58E-05	1.08E-03
reproduction (GO:0000003)	1462	278	213.53	+	1.30	4.56E-05	1.08E-03
positive regulation of immune response (GO:0050778)	747	67	109.10	-	.61	4.53E-05	1.07E-03
smooth muscle contraction (GO:0006939)	49	22	7.16	+	3.07	4.51E-05	1.07E-03
double-strand break repair (GO:0006302)	204	9	29.80	-	.30	4.49E-05	1.07E-03
cellular response to organic cyclic compound (GO:0071407)	511	115	74.63	+	1.54	4.43E-05	1.05E-03
ameboidal-type cell migration (GO:0001667)	181	52	26.44	+	1.97	4.37E-05	1.04E-03
protein modification by small protein conjugation (GO:0032446)	822	76	120.06	-	.63	4.32E-05	1.03E-03
cell differentiation involved in kidney development (GO:0061005)	45	21	6.57	+	3.20	4.30E-05	1.03E-03
regulation of BMP signaling pathway (GO:0030510)	101	35	14.75	+	2.37	4.28E-05	1.02E-03
epithelial cell differentiation involved in kidney development (GO:0035850)	34	18	4.97	+	3.62	4.27E-05	1.02E-03
positive regulation of cellular protein metabolic process (GO:0032270)	1474	280	215.28	+	1.30	4.18E-05	1.00E-03
organonitrogen compound catabolic process (GO:1901565)	1091	108	159.35	-	.68	4.16E-05	9.99E-04
positive regulation of hormone secretion (GO:0046887)	137	43	20.01	+	2.15	4.02E-05	9.68E-04
activation of adenylate cyclase activity (GO:0007190)	41	20	5.99	+	3.34	4.01E-05	9.67E-04
roof of mouth development (GO:0060021)	87	32	12.71	+	2.52	4.00E-05	9.64E-04
sensory perception of pain (GO:0019233)	75	29	10.95	+	2.65	3.96E-05	9.56E-04
positive regulation of cell migration (GO:0030335)	520	117	75.95	+	1.54	3.94E-05	9.53E-04
chemical synaptic transmission, postsynaptic (GO:0099565)	68	27	9.93	+	2.72	3.92E-05	9.51E-04
neural retina development (GO:0003407)	68	27	9.93	+	2.72	3.92E-05	9.50E-04
viral transcription (GO:0019083)	116	2	16.94	-	.12	3.76E-05	9.14E-04
immune response-activating cell surface receptor signaling pathway (GO:0002429)	455	34	66.45	-	.51	3.68E-05	8.98E-04
immune response-activating signal transduction (GO:0002757)	455	34	66.45	-	.51	3.68E-05	8.96E-04
positive regulation of developmental growth (GO:0048639)	169	50	24.68	+	2.03	3.66E-05	8.95E-04
sodium ion transmembrane transport (GO:0035725)	119	39	17.38	+	2.24	3.63E-05	8.92E-04
embryonic limb morphogenesis (GO:0030326)	119	39	17.38	+	2.24	3.63E-05	8.90E-04
embryonic appendage morphogenesis (GO:0035113)	119	39	17.38	+	2.24	3.63E-05	8.89E-04
aortic valve development (GO:0003176)	37	19	5.40	+	3.52	3.63E-05	8.88E-04
keratinocyte differentiation (GO:0030216)	270	15	39.43	-	.38	3.44E-05	8.47E-04
keratinization (GO:0031424)	227	11	33.15	-	.33	3.43E-05	8.46E-04
peripheral nervous system development (GO:0007422)	79	30	11.54	+	2.60	3.34E-05	8.26E-04
electron transport chain (GO:0022900)	170	6	24.83	-	.24	3.33E-05	8.26E-04
somite development (GO:0061053)	79	30	11.54	+	2.60	3.34E-05	8.25E-04
regulation of odontogenesis (GO:0042481)	17	13	2.48	+	5.24	3.29E-05	8.16E-04
outflow tract morphogenesis (GO:0003151)	67	27	9.79	+	2.76	3.26E-05	8.11E-04
regulation of telomere maintenance (GO:0032204)	81	0	11.83	-	 < 0.01	3.08E-05	7.67E-04
cellular homeostasis (GO:0019725)	895	184	130.72	+	1.41	3.05E-05	7.60E-04
SMAD protein signal transduction (GO:0060395)	62	26	9.06	+	2.87	3.04E-05	7.59E-04
DNA-dependent DNA replication (GO:0006261)	195	8	28.48	-	.28	2.96E-05	7.42E-04
negative regulation of nervous system development (GO:0051961)	148	46	21.62	+	2.13	2.96E-05	7.41E-04
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	262	69	38.27	+	1.80	2.96E-05	7.41E-04
regulation of AMPA receptor activity (GO:2000311)	26	16	3.80	+	4.21	2.92E-05	7.33E-04
autonomic nervous system development (GO:0048483)	47	22	6.86	+	3.20	2.75E-05	6.93E-04
negative regulation of Wnt signaling pathway (GO:0030178)	219	61	31.99	+	1.91	2.75E-05	6.92E-04
cellular response to lipid (GO:0071396)	481	111	70.25	+	1.58	2.64E-05	6.67E-04
negative regulation of cell development (GO:0010721)	180	53	26.29	+	2.02	2.63E-05	6.64E-04
DNA replication (GO:0006260)	273	15	39.87	-	.38	2.57E-05	6.52E-04
branching involved in ureteric bud morphogenesis (GO:0001658)	43	21	6.28	+	3.34	2.56E-05	6.50E-04
protein-DNA complex subunit organization (GO:0071824)	296	17	43.23	-	.39	2.47E-05	6.28E-04
regulation of axonogenesis (GO:0050770)	161	49	23.51	+	2.08	2.43E-05	6.19E-04
regulation of Wnt signaling pathway (GO:0030111)	377	92	55.06	+	1.67	2.40E-05	6.12E-04
female sex differentiation (GO:0046660)	107	37	15.63	+	2.37	2.38E-05	6.08E-04
positive regulation of cation channel activity (GO:2001259)	76	30	11.10	+	2.70	2.38E-05	6.07E-04
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	60	26	8.76	+	2.97	2.35E-05	6.01E-04
viral gene expression (GO:0019080)	172	6	25.12	-	.24	2.34E-05	6.00E-04
heart valve development (GO:0003170)	65	27	9.49	+	2.84	2.31E-05	5.93E-04
calcium ion transport (GO:0006816)	244	66	35.64	+	1.85	2.27E-05	5.85E-04
hippocampus development (GO:0021766)	81	31	11.83	+	2.62	2.20E-05	5.69E-04
negative regulation of metabolic process (GO:0009892)	3095	544	452.04	+	1.20	2.17E-05	5.60E-04
cellular response to hormone stimulus (GO:0032870)	529	120	77.26	+	1.55	2.13E-05	5.52E-04
nuclear division (GO:0000280)	339	21	49.51	-	.42	2.10E-05	5.44E-04
regulation of calcium ion transport (GO:0051924)	252	68	36.81	+	1.85	2.03E-05	5.28E-04
negative regulation of response to external stimulus (GO:0032102)	559	126	81.64	+	1.54	2.01E-05	5.23E-04
ribonucleoprotein complex assembly (GO:0022618)	189	7	27.60	-	.25	2.00E-05	5.21E-04
regulation of metal ion transport (GO:0010959)	262	70	38.27	+	1.83	1.99E-05	5.19E-04
limb morphogenesis (GO:0035108)	141	45	20.59	+	2.19	1.96E-05	5.12E-04
appendage morphogenesis (GO:0035107)	141	45	20.59	+	2.19	1.96E-05	5.12E-04
protein deubiquitination (GO:0016579)	278	15	40.60	-	.37	1.93E-05	5.06E-04
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	301	17	43.96	-	.39	1.91E-05	5.00E-04
negative regulation of cellular component movement (GO:0051271)	293	76	42.79	+	1.78	1.89E-05	4.98E-04
regulation of angiogenesis (GO:0045765)	282	74	41.19	+	1.80	1.87E-05	4.93E-04
DNA recombination (GO:0006310)	225	10	32.86	-	.30	1.82E-05	4.81E-04
bone morphogenesis (GO:0060349)	97	35	14.17	+	2.47	1.81E-05	4.78E-04
negative regulation of macromolecule metabolic process (GO:0010605)	2880	511	420.64	+	1.21	1.80E-05	4.75E-04
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	198	57	28.92	+	1.97	1.78E-05	4.73E-04
mitotic cell cycle process (GO:1903047)	675	57	98.59	-	.58	1.76E-05	4.69E-04
metal ion transport (GO:0030001)	326	83	47.61	+	1.74	1.73E-05	4.60E-04
protein metabolic process (GO:0019538)	4203	514	613.87	-	.84	1.72E-05	4.59E-04
complement activation (GO:0006956)	177	6	25.85	-	.23	1.69E-05	4.52E-04
dopaminergic neuron differentiation (GO:0071542)	31	18	4.53	+	3.98	1.69E-05	4.51E-04
regulation of vesicle-mediated transport (GO:0060627)	530	121	77.41	+	1.56	1.64E-05	4.39E-04
columnar/cuboidal epithelial cell differentiation (GO:0002065)	78	31	11.39	+	2.72	1.58E-05	4.23E-04
regulation of vasculature development (GO:1901342)	286	75	41.77	+	1.80	1.53E-05	4.13E-04
macromolecule modification (GO:0043412)	3211	379	468.98	-	.81	1.53E-05	4.11E-04
central nervous system neuron development (GO:0021954)	88	33	12.85	+	2.57	1.51E-05	4.07E-04
mesoderm formation (GO:0001707)	67	28	9.79	+	2.86	1.50E-05	4.05E-04
regulation of transferase activity (GO:0051338)	1033	210	150.87	+	1.39	1.45E-05	3.92E-04
mRNA 3'-end processing (GO:0031124)	88	0	12.85	-	 < 0.01	1.40E-05	3.78E-04
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	165	5	24.10	-	.21	1.39E-05	3.77E-04
mesoderm development (GO:0007498)	121	41	17.67	+	2.32	1.38E-05	3.76E-04
tRNA metabolic process (GO:0006399)	190	7	27.75	-	.25	1.36E-05	3.71E-04
glutamate receptor signaling pathway (GO:0007215)	48	23	7.01	+	3.28	1.36E-05	3.71E-04
limb development (GO:0060173)	175	53	25.56	+	2.07	1.33E-05	3.64E-04
appendage development (GO:0048736)	175	53	25.56	+	2.07	1.33E-05	3.63E-04
metanephros morphogenesis (GO:0003338)	27	17	3.94	+	4.31	1.33E-05	3.63E-04
signal release (GO:0023061)	157	49	22.93	+	2.14	1.25E-05	3.45E-04
negative regulation of neuron death (GO:1901215)	209	60	30.53	+	1.97	1.24E-05	3.41E-04
positive regulation of transmembrane transport (GO:0034764)	238	66	34.76	+	1.90	1.23E-05	3.38E-04
bone development (GO:0060348)	189	56	27.60	+	2.03	1.13E-05	3.13E-04
regulation of epithelial cell differentiation (GO:0030856)	147	47	21.47	+	2.19	1.11E-05	3.07E-04
epithelial cell differentiation (GO:0030855)	686	150	100.19	+	1.50	1.11E-05	3.06E-04
chromosome segregation (GO:0007059)	286	15	41.77	-	.36	1.09E-05	3.04E-04
adult locomotory behavior (GO:0008344)	74	30	10.81	+	2.78	1.08E-05	3.01E-04
activation of immune response (GO:0002253)	530	40	77.41	-	.52	1.05E-05	2.92E-04
regulation of muscle contraction (GO:0006937)	161	50	23.51	+	2.13	1.04E-05	2.92E-04
negative regulation of neuron apoptotic process (GO:0043524)	146	47	21.32	+	2.20	1.02E-05	2.85E-04
response to metal ion (GO:0010038)	379	94	55.35	+	1.70	1.01E-05	2.82E-04
negative regulation of cell motility (GO:2000146)	285	76	41.63	+	1.83	1.01E-05	2.82E-04
regulation of morphogenesis of an epithelium (GO:1905330)	64	28	9.35	+	3.00	9.94E-06	2.80E-04
cellular response to retinoic acid (GO:0071300)	69	29	10.08	+	2.88	9.74E-06	2.75E-04
response to nitrogen compound (GO:1901698)	1101	223	160.81	+	1.39	9.78E-06	2.75E-04
mesoderm morphogenesis (GO:0048332)	69	29	10.08	+	2.88	9.74E-06	2.75E-04
regulation of ossification (GO:0030278)	115	40	16.80	+	2.38	9.23E-06	2.61E-04
multicellular organismal signaling (GO:0035637)	128	43	18.70	+	2.30	8.78E-06	2.49E-04
regulation of animal organ morphogenesis (GO:2000027)	183	55	26.73	+	2.06	8.75E-06	2.49E-04
response to inorganic substance (GO:0010035)	553	127	80.77	+	1.57	8.35E-06	2.38E-04
organelle fission (GO:0048285)	369	23	53.89	-	.43	8.35E-06	2.38E-04
translational initiation (GO:0006413)	143	3	20.89	-	.14	8.13E-06	2.32E-04
respiratory system development (GO:0060541)	200	59	29.21	+	2.02	8.06E-06	2.31E-04
negative regulation of cellular metabolic process (GO:0031324)	2613	472	381.64	+	1.24	8.07E-06	2.31E-04
metanephric nephron development (GO:0072210)	32	19	4.67	+	4.07	7.80E-06	2.24E-04
response to glucocorticoid (GO:0051384)	149	48	21.76	+	2.21	7.66E-06	2.21E-04
sensory perception of sound (GO:0007605)	156	50	22.78	+	2.19	7.29E-06	2.10E-04
positive regulation of cell motility (GO:2000147)	545	126	79.60	+	1.58	7.25E-06	2.10E-04
muscle tissue morphogenesis (GO:0060415)	67	29	9.79	+	2.96	7.26E-06	2.10E-04
positive regulation of cellular component movement (GO:0051272)	558	128	81.50	+	1.57	7.12E-06	2.07E-04
nerve development (GO:0021675)	76	31	11.10	+	2.79	7.04E-06	2.04E-04
ribonucleoprotein complex subunit organization (GO:0071826)	196	7	28.63	-	.24	6.89E-06	2.01E-04
response to alcohol (GO:0097305)	253	70	36.95	+	1.89	6.90E-06	2.01E-04
activation of protein kinase activity (GO:0032147)	328	85	47.91	+	1.77	6.74E-06	1.97E-04
regulation of neuron death (GO:1901214)	316	83	46.15	+	1.80	6.59E-06	1.93E-04
cardiac septum morphogenesis (GO:0060411)	66	29	9.64	+	3.01	6.47E-06	1.90E-04
regulation of synapse assembly (GO:0051963)	99	37	14.46	+	2.56	6.42E-06	1.89E-04
regulation of cartilage development (GO:0061035)	71	30	10.37	+	2.89	6.33E-06	1.86E-04
mitochondrial translation (GO:0032543)	112	1	16.36	-	.06	6.23E-06	1.84E-04
respiratory electron transport chain (GO:0022904)	112	1	16.36	-	.06	6.23E-06	1.84E-04
cardiac conduction system development (GO:0003161)	38	21	5.55	+	3.78	6.10E-06	1.81E-04
response to external stimulus (GO:0009605)	2525	459	368.79	+	1.24	6.00E-06	1.78E-04
negative regulation of cell migration (GO:0030336)	270	74	39.43	+	1.88	6.00E-06	1.78E-04
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	420	103	61.34	+	1.68	5.72E-06	1.70E-04
mesonephric tubule morphogenesis (GO:0072171)	52	25	7.59	+	3.29	5.58E-06	1.66E-04
associative learning (GO:0008306)	79	32	11.54	+	2.77	5.55E-06	1.66E-04
positive regulation of animal organ morphogenesis (GO:0110110)	31	19	4.53	+	4.20	5.55E-06	1.66E-04
collagen fibril organization (GO:0030199)	103	38	15.04	+	2.53	5.37E-06	1.62E-04
complement activation, classical pathway (GO:0006958)	161	4	23.51	-	.17	5.38E-06	1.61E-04
cardiac septum development (GO:0003279)	103	38	15.04	+	2.53	5.37E-06	1.61E-04
artery morphogenesis (GO:0048844)	63	28	9.20	+	3.04	5.11E-06	1.54E-04
negative regulation of secretion (GO:0051048)	165	52	24.10	+	2.16	5.05E-06	1.53E-04
mitotic cell cycle (GO:0000278)	750	63	109.54	-	.58	4.97E-06	1.50E-04
response to steroid hormone (GO:0048545)	285	77	41.63	+	1.85	4.95E-06	1.50E-04
cellular amide metabolic process (GO:0043603)	820	71	119.76	-	.59	4.83E-06	1.47E-04
mitochondrion organization (GO:0007005)	468	32	68.35	-	.47	4.80E-06	1.46E-04
mammary gland development (GO:0030879)	128	44	18.70	+	2.35	4.81E-06	1.46E-04
positive regulation of epithelial cell differentiation (GO:0030858)	55	26	8.03	+	3.24	4.63E-06	1.42E-04
ventral spinal cord development (GO:0021517)	44	23	6.43	+	3.58	4.54E-06	1.39E-04
pituitary gland development (GO:0021983)	44	23	6.43	+	3.58	4.54E-06	1.39E-04
protein modification by small protein removal (GO:0070646)	295	15	43.09	-	.35	4.36E-06	1.34E-04
positive regulation of ion transmembrane transport (GO:0034767)	187	57	27.31	+	2.09	4.34E-06	1.34E-04
mesenchyme morphogenesis (GO:0072132)	51	25	7.45	+	3.36	4.28E-06	1.32E-04
ureteric bud morphogenesis (GO:0060675)	51	25	7.45	+	3.36	4.28E-06	1.32E-04
positive regulation of cellular component organization (GO:0051130)	1161	236	169.57	+	1.39	4.17E-06	1.29E-04
axis specification (GO:0009798)	88	35	12.85	+	2.72	3.67E-06	1.14E-04
B cell mediated immunity (GO:0019724)	205	7	29.94	-	.23	3.60E-06	1.13E-04
intracellular protein transport (GO:0006886)	781	66	114.07	-	.58	3.61E-06	1.12E-04
response to organonitrogen compound (GO:0010243)	1014	211	148.10	+	1.42	3.61E-06	1.12E-04
regulation of MAPK cascade (GO:0043408)	707	157	103.26	+	1.52	3.43E-06	1.07E-04
regulation of protein modification process (GO:0031399)	1654	320	241.57	+	1.32	3.13E-06	9.81E-05
cell cycle process (GO:0022402)	957	86	139.77	-	.62	3.07E-06	9.64E-05
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	86	35	12.56	+	2.79	3.03E-06	9.53E-05
retina development in camera-type eye (GO:0060041)	148	49	21.62	+	2.27	2.88E-06	9.10E-05
dorsal spinal cord development (GO:0021516)	20	16	2.92	+	5.48	2.72E-06	8.60E-05
negative regulation of nitrogen compound metabolic process (GO:0051172)	2453	451	358.27	+	1.26	2.61E-06	8.27E-05
positive regulation of catalytic activity (GO:0043085)	1240	251	181.11	+	1.39	2.53E-06	8.04E-05
odontogenesis (GO:0042476)	120	43	17.53	+	2.45	2.50E-06	7.94E-05
regulation of smooth muscle contraction (GO:0006940)	60	28	8.76	+	3.20	2.46E-06	7.84E-05
positive regulation of locomotion (GO:0040017)	560	131	81.79	+	1.60	2.46E-06	7.83E-05
negative regulation of locomotion (GO:0040013)	317	85	46.30	+	1.84	2.34E-06	7.49E-05
muscle organ morphogenesis (GO:0048644)	74	32	10.81	+	2.96	2.29E-06	7.33E-05
regulation of apoptotic process (GO:0042981)	1493	294	218.06	+	1.35	2.23E-06	7.17E-05
response to corticosteroid (GO:0031960)	168	54	24.54	+	2.20	2.23E-06	7.17E-05
synapse assembly (GO:0007416)	99	38	14.46	+	2.63	2.21E-06	7.14E-05
positive regulation of cytosolic calcium ion concentration (GO:0007204)	283	78	41.33	+	1.89	2.20E-06	7.12E-05
intracellular signal transduction (GO:0035556)	1677	325	244.93	+	1.33	2.16E-06	7.00E-05
cellular response to BMP stimulus (GO:0071773)	94	37	13.73	+	2.69	2.08E-06	6.75E-05
response to BMP (GO:0071772)	94	37	13.73	+	2.69	2.08E-06	6.74E-05
cytoplasmic translation (GO:0002181)	122	1	17.82	-	.06	1.90E-06	6.18E-05
cardiac ventricle development (GO:0003231)	123	44	17.96	+	2.45	1.89E-06	6.16E-05
neuron fate specification (GO:0048665)	28	19	4.09	+	4.65	1.86E-06	6.10E-05
neuromuscular process (GO:0050905)	136	47	19.86	+	2.37	1.86E-06	6.10E-05
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	120	1	17.53	-	.06	1.84E-06	6.05E-05
muscle cell differentiation (GO:0042692)	247	71	36.08	+	1.97	1.72E-06	5.65E-05
cell junction assembly (GO:0034329)	276	77	40.31	+	1.91	1.70E-06	5.62E-05
regulation of cell growth (GO:0001558)	422	106	61.64	+	1.72	1.70E-06	5.62E-05
positive regulation of cation transmembrane transport (GO:1904064)	171	55	24.98	+	2.20	1.68E-06	5.58E-05
chromosome organization (GO:0051276)	1064	97	155.40	-	.62	1.60E-06	5.32E-05
macromolecule biosynthetic process (GO:0009059)	1680	172	245.37	-	.70	1.59E-06	5.30E-05
positive regulation of potassium ion transmembrane transport (GO:1901381)	62	29	9.06	+	3.20	1.58E-06	5.26E-05
mitochondrial respiratory chain complex assembly (GO:0033108)	101	0	14.75	-	 < 0.01	1.55E-06	5.19E-05
rRNA metabolic process (GO:0016072)	272	12	39.73	-	.30	1.55E-06	5.19E-05
cellular response to oxygen-containing compound (GO:1901701)	1075	224	157.01	+	1.43	1.54E-06	5.16E-05
regulation of protein kinase activity (GO:0045859)	802	176	117.14	+	1.50	1.48E-06	4.98E-05
sex differentiation (GO:0007548)	272	77	39.73	+	1.94	1.39E-06	4.67E-05
endocrine pancreas development (GO:0031018)	40	23	5.84	+	3.94	1.34E-06	4.53E-05
nervous system process (GO:0050877)	1416	283	206.81	+	1.37	1.27E-06	4.31E-05
negative regulation of growth (GO:0045926)	249	72	36.37	+	1.98	1.23E-06	4.17E-05
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	100	39	14.61	+	2.67	1.23E-06	4.17E-05
cellular cation homeostasis (GO:0030003)	642	148	93.77	+	1.58	1.21E-06	4.13E-05
cell fate determination (GO:0001709)	43	24	6.28	+	3.82	1.18E-06	4.04E-05
regulation of potassium ion transmembrane transport (GO:1901379)	106	41	15.48	+	2.65	1.18E-06	4.04E-05
pallium development (GO:0021543)	173	56	25.27	+	2.22	1.16E-06	3.99E-05
ossification (GO:0001503)	267	76	39.00	+	1.95	1.14E-06	3.91E-05
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	522	126	76.24	+	1.65	1.13E-06	3.88E-05
positive regulation of protein modification process (GO:0031401)	1079	226	157.59	+	1.43	1.05E-06	3.61E-05
immunoglobulin mediated immune response (GO:0016064)	201	6	29.36	-	.20	1.01E-06	3.48E-05
defense response to other organism (GO:0098542)	1038	93	151.60	-	.61	9.50E-07	3.29E-05
cell population proliferation (GO:0008283)	485	119	70.84	+	1.68	9.25E-07	3.22E-05
regulation of catecholamine secretion (GO:0050433)	56	28	8.18	+	3.42	8.59E-07	2.99E-05
multicellular organismal response to stress (GO:0033555)	67	31	9.79	+	3.17	8.37E-07	2.92E-05
cartilage development (GO:0051216)	153	52	22.35	+	2.33	8.13E-07	2.84E-05
positive regulation of secretion by cell (GO:1903532)	288	81	42.06	+	1.93	8.10E-07	2.84E-05
response to drug (GO:0042493)	394	102	57.55	+	1.77	7.94E-07	2.79E-05
regulation of blood pressure (GO:0008217)	188	60	27.46	+	2.19	7.05E-07	2.48E-05
stem cell differentiation (GO:0048863)	157	53	22.93	+	2.31	7.00E-07	2.47E-05
artery development (GO:0060840)	89	37	13.00	+	2.85	6.47E-07	2.29E-05
cell cycle (GO:0007049)	1316	125	192.21	-	.65	6.23E-07	2.21E-05
nephron tubule morphogenesis (GO:0072078)	62	30	9.06	+	3.31	6.05E-07	2.15E-05
positive regulation of transferase activity (GO:0051347)	693	159	101.22	+	1.57	5.89E-07	2.10E-05
regulation of programmed cell death (GO:0043067)	1532	305	223.76	+	1.36	5.74E-07	2.05E-05
negative regulation of transport (GO:0051051)	430	110	62.80	+	1.75	5.72E-07	2.05E-05
response to retinoic acid (GO:0032526)	111	43	16.21	+	2.65	5.69E-07	2.04E-05
peptide metabolic process (GO:0006518)	544	37	79.45	-	.47	5.49E-07	1.97E-05
negative regulation of apoptotic process (GO:0043066)	895	196	130.72	+	1.50	4.67E-07	1.68E-05
cellular metal ion homeostasis (GO:0006875)	561	135	81.94	+	1.65	4.51E-07	1.63E-05
regulation of protein secretion (GO:0050708)	283	81	41.33	+	1.96	4.42E-07	1.60E-05
positive regulation of cell projection organization (GO:0031346)	353	95	51.56	+	1.84	4.41E-07	1.60E-05
regulation of cell adhesion (GO:0030155)	731	167	106.77	+	1.56	3.88E-07	1.42E-05
nephron epithelium morphogenesis (GO:0072088)	64	31	9.35	+	3.32	3.88E-07	1.41E-05
cell-cell adhesion (GO:0098609)	515	127	75.22	+	1.69	3.89E-07	1.41E-05
positive regulation of intracellular signal transduction (GO:1902533)	1040	222	151.90	+	1.46	3.57E-07	1.31E-05
rRNA processing (GO:0006364)	262	10	38.27	-	.26	3.49E-07	1.28E-05
inner ear morphogenesis (GO:0042472)	101	41	14.75	+	2.78	3.38E-07	1.24E-05
positive regulation of synaptic transmission (GO:0050806)	135	49	19.72	+	2.49	3.31E-07	1.22E-05
cellular ion homeostasis (GO:0006873)	659	154	96.25	+	1.60	3.24E-07	1.20E-05
developmental process involved in reproduction (GO:0003006)	974	211	142.26	+	1.48	3.16E-07	1.17E-05
innate immune response (GO:0045087)	848	69	123.85	-	.56	3.05E-07	1.13E-05
cellular chemical homeostasis (GO:0055082)	762	173	111.29	+	1.55	2.98E-07	1.11E-05
cardiac muscle tissue development (GO:0048738)	168	57	24.54	+	2.32	2.92E-07	1.09E-05
regulation of nervous system process (GO:0031644)	146	52	21.32	+	2.44	2.62E-07	9.79E-06
cellular macromolecule biosynthetic process (GO:0034645)	1639	162	239.38	-	.68	2.52E-07	9.45E-06
nephron morphogenesis (GO:0072028)	66	32	9.64	+	3.32	2.49E-07	9.36E-06
kidney morphogenesis (GO:0060993)	83	37	12.12	+	3.05	2.33E-07	8.77E-06
gastrulation (GO:0007369)	157	55	22.93	+	2.40	2.13E-07	8.03E-06
regulation of synaptic transmission, glutamatergic (GO:0051966)	69	33	10.08	+	3.27	2.08E-07	7.89E-06
positive regulation of potassium ion transport (GO:0043268)	69	33	10.08	+	3.27	2.08E-07	7.87E-06
muscle organ development (GO:0007517)	283	82	41.33	+	1.98	2.07E-07	7.86E-06
cellular response to DNA damage stimulus (GO:0006974)	793	62	115.82	-	.54	2.03E-07	7.72E-06
positive regulation of protein kinase activity (GO:0045860)	539	133	78.72	+	1.69	2.00E-07	7.64E-06
protein-containing complex assembly (GO:0065003)	1358	127	198.34	-	.64	1.99E-07	7.60E-06
blood vessel diameter maintenance (GO:0097746)	130	49	18.99	+	2.58	1.93E-07	7.42E-06
regulation of tube diameter (GO:0035296)	130	49	18.99	+	2.58	1.93E-07	7.40E-06
positive regulation of cell development (GO:0010720)	300	86	43.82	+	1.96	1.81E-07	7.02E-06
regulation of kinase activity (GO:0043549)	914	202	133.49	+	1.51	1.81E-07	7.01E-06
negative regulation of programmed cell death (GO:0043069)	914	202	133.49	+	1.51	1.81E-07	7.00E-06
segmentation (GO:0035282)	95	40	13.88	+	2.88	1.78E-07	6.90E-06
regulation of cellular response to growth factor stimulus (GO:0090287)	299	86	43.67	+	1.97	1.73E-07	6.74E-06
detection of stimulus (GO:0051606)	721	54	105.31	-	.51	1.70E-07	6.64E-06
regulation of signaling receptor activity (GO:0010469)	188	62	27.46	+	2.26	1.68E-07	6.56E-06
positive regulation of neurogenesis (GO:0050769)	227	71	33.15	+	2.14	1.59E-07	6.23E-06
response to hormone (GO:0009725)	819	185	119.62	+	1.55	1.56E-07	6.13E-06
catabolic process (GO:0009056)	2096	217	306.13	-	.71	1.43E-07	5.62E-06
adult behavior (GO:0030534)	133	50	19.43	+	2.57	1.40E-07	5.52E-06
ubiquitin-dependent protein catabolic process (GO:0006511)	545	35	79.60	-	.44	1.33E-07	5.27E-06
positive regulation of secretion (GO:0051047)	317	90	46.30	+	1.94	1.16E-07	4.62E-06
regulation of anatomical structure size (GO:0090066)	514	129	75.07	+	1.72	1.11E-07	4.42E-06
cell differentiation in spinal cord (GO:0021515)	49	28	7.16	+	3.91	1.08E-07	4.33E-06
mitochondrial gene expression (GO:0140053)	142	1	20.74	-	.05	1.07E-07	4.32E-06
RNA 3'-end processing (GO:0031123)	142	1	20.74	-	.05	1.07E-07	4.31E-06
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	253	77	36.95	+	2.08	1.07E-07	4.30E-06
negative regulation of neuron differentiation (GO:0045665)	70	34	10.22	+	3.33	1.03E-07	4.16E-06
embryonic pattern specification (GO:0009880)	70	34	10.22	+	3.33	1.03E-07	4.15E-06
regulation of amine transport (GO:0051952)	92	40	13.44	+	2.98	1.00E-07	4.06E-06
formation of primary germ layer (GO:0001704)	112	45	16.36	+	2.75	9.84E-08	4.00E-06
mesonephric tubule development (GO:0072164)	81	37	11.83	+	3.13	9.75E-08	3.98E-06
mesonephric epithelium development (GO:0072163)	81	37	11.83	+	3.13	9.75E-08	3.97E-06
renal tubule morphogenesis (GO:0061333)	66	33	9.64	+	3.42	9.36E-08	3.83E-06
nuclear-transcribed mRNA catabolic process (GO:0000956)	195	4	28.48	-	.14	8.75E-08	3.59E-06
eye morphogenesis (GO:0048592)	152	55	22.20	+	2.48	8.02E-08	3.30E-06
positive regulation of neuron differentiation (GO:0045666)	95	41	13.88	+	2.95	7.80E-08	3.23E-06
modification-dependent protein catabolic process (GO:0019941)	552	35	80.62	-	.43	7.82E-08	3.23E-06
positive regulation of MAPK cascade (GO:0043410)	525	132	76.68	+	1.72	7.62E-08	3.18E-06
ureteric bud development (GO:0001657)	80	37	11.68	+	3.17	7.62E-08	3.17E-06
regulation of neurotransmitter receptor activity (GO:0099601)	80	37	11.68	+	3.17	7.62E-08	3.16E-06
negative regulation of cell death (GO:0060548)	1008	221	147.22	+	1.50	7.43E-08	3.11E-06
protein modification by small protein conjugation or removal (GO:0070647)	1035	87	151.17	-	.58	7.06E-08	2.96E-06
regulation of tube size (GO:0035150)	131	50	19.13	+	2.61	6.97E-08	2.93E-06
regulation of cell death (GO:0010941)	1668	335	243.62	+	1.38	6.54E-08	2.76E-06
mRNA catabolic process (GO:0006402)	215	5	31.40	-	.16	6.36E-08	2.69E-06
intracellular transport (GO:0046907)	1464	137	213.82	-	.64	6.26E-08	2.65E-06
camera-type eye morphogenesis (GO:0048593)	125	49	18.26	+	2.68	6.00E-08	2.55E-06
immune response (GO:0006955)	2075	212	303.06	-	.70	5.94E-08	2.53E-06
neurotransmitter transport (GO:0006836)	142	53	20.74	+	2.56	5.75E-08	2.46E-06
localization (GO:0051179)	5831	998	851.65	+	1.17	5.70E-08	2.44E-06
regulation of developmental growth (GO:0048638)	320	92	46.74	+	1.97	5.68E-08	2.44E-06
learning (GO:0007612)	146	54	21.32	+	2.53	5.04E-08	2.17E-06
homeostatic process (GO:0042592)	1680	338	245.37	+	1.38	4.88E-08	2.11E-06
mesonephros development (GO:0001823)	85	39	12.41	+	3.14	4.05E-08	1.75E-06
branching morphogenesis of an epithelial tube (GO:0048754)	132	51	19.28	+	2.65	3.93E-08	1.71E-06
embryonic skeletal system morphogenesis (GO:0048704)	95	42	13.88	+	3.03	3.57E-08	1.56E-06
nephron tubule development (GO:0072080)	77	37	11.25	+	3.29	3.56E-08	1.55E-06
positive regulation of molecular function (GO:0044093)	1618	329	236.32	+	1.39	3.53E-08	1.55E-06
cellular protein metabolic process (GO:0044267)	3590	405	524.34	-	.77	3.30E-08	1.45E-06
morphogenesis of a branching epithelium (GO:0061138)	160	58	23.37	+	2.48	3.07E-08	1.35E-06
forebrain generation of neurons (GO:0021872)	62	33	9.06	+	3.64	3.01E-08	1.33E-06
pancreas development (GO:0031016)	69	35	10.08	+	3.47	2.93E-08	1.30E-06
dorsal/ventral pattern formation (GO:0009953)	76	37	11.10	+	3.33	2.74E-08	1.21E-06
sensory perception of mechanical stimulus (GO:0050954)	177	62	25.85	+	2.40	2.70E-08	1.20E-06
cellular catabolic process (GO:0044248)	1812	177	264.65	-	.67	2.62E-08	1.17E-06
modification-dependent macromolecule catabolic process (GO:0043632)	563	35	82.23	-	.43	2.58E-08	1.16E-06
RNA catabolic process (GO:0006401)	248	7	36.22	-	.19	2.52E-08	1.13E-06
feeding behavior (GO:0007631)	83	39	12.12	+	3.22	2.46E-08	1.11E-06
forebrain neuron differentiation (GO:0021879)	51	30	7.45	+	4.03	2.37E-08	1.07E-06
regulation of insulin secretion (GO:0050796)	189	65	27.60	+	2.35	2.29E-08	1.04E-06
connective tissue development (GO:0061448)	202	68	29.50	+	2.30	2.15E-08	9.78E-07
morphogenesis of a branching structure (GO:0001763)	169	61	24.68	+	2.47	2.14E-08	9.73E-07
regulation of synapse organization (GO:0050807)	210	70	30.67	+	2.28	2.09E-08	9.56E-07
metal ion homeostasis (GO:0055065)	626	154	91.43	+	1.68	2.09E-08	9.55E-07
mesenchymal cell differentiation (GO:0048762)	162	59	23.66	+	2.49	2.06E-08	9.47E-07
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1528	315	223.17	+	1.41	1.96E-08	9.06E-07
RNA splicing (GO:0008380)	409	20	59.74	-	.33	1.96E-08	9.03E-07
regulation of potassium ion transport (GO:0043266)	120	49	17.53	+	2.80	1.81E-08	8.43E-07
ear morphogenesis (GO:0042471)	120	49	17.53	+	2.80	1.81E-08	8.40E-07
regulation of cytosolic calcium ion concentration (GO:0051480)	321	94	46.88	+	2.00	1.78E-08	8.28E-07
ribosome biogenesis (GO:0042254)	329	13	48.05	-	.27	1.76E-08	8.24E-07
cation homeostasis (GO:0055080)	710	170	103.70	+	1.64	1.68E-08	7.90E-07
regulation of synapse structure or activity (GO:0050803)	221	73	32.28	+	2.26	1.59E-08	7.50E-07
regulation of gene expression (GO:0010468)	4922	864	718.88	+	1.20	1.56E-08	7.38E-07
cardiac chamber morphogenesis (GO:0003206)	119	49	17.38	+	2.82	1.54E-08	7.31E-07
regulation of postsynaptic membrane potential (GO:0060078)	99	44	14.46	+	3.04	1.51E-08	7.16E-07
renal tubule development (GO:0061326)	81	39	11.83	+	3.30	1.47E-08	7.03E-07
angiogenesis (GO:0001525)	318	94	46.45	+	2.02	1.47E-08	7.01E-07
positive regulation of signal transduction (GO:0009967)	1584	326	231.35	+	1.41	1.43E-08	6.84E-07
organic substance catabolic process (GO:1901575)	1769	170	258.37	-	.66	1.19E-08	5.72E-07
regulation of synaptic plasticity (GO:0048167)	188	66	27.46	+	2.40	1.12E-08	5.42E-07
cardiac chamber development (GO:0003205)	162	60	23.66	+	2.54	1.11E-08	5.36E-07
regulation of cellular component organization (GO:0051128)	2390	462	349.07	+	1.32	1.01E-08	4.89E-07
immunoglobulin production (GO:0002377)	138	0	20.16	-	 < 0.01	9.88E-09	4.81E-07
protein catabolic process (GO:0030163)	697	47	101.80	-	.46	9.52E-09	4.64E-07
inorganic ion homeostasis (GO:0098771)	724	174	105.74	+	1.65	9.27E-09	4.54E-07
regulation of phosphate metabolic process (GO:0019220)	1578	326	230.47	+	1.41	8.96E-09	4.41E-07
regulation of phosphorus metabolic process (GO:0051174)	1578	326	230.47	+	1.41	8.96E-09	4.40E-07
diencephalon development (GO:0021536)	79	39	11.54	+	3.38	8.67E-09	4.28E-07
regulation of nucleobase-containing compound metabolic process (GO:0019219)	4049	730	591.38	+	1.23	8.29E-09	4.11E-07
proteolysis involved in cellular protein catabolic process (GO:0051603)	609	38	88.95	-	.43	7.45E-09	3.70E-07
cellular calcium ion homeostasis (GO:0006874)	425	117	62.07	+	1.88	6.99E-09	3.48E-07
regulation of heart contraction (GO:0008016)	230	76	33.59	+	2.26	6.77E-09	3.39E-07
cell surface receptor signaling pathway (GO:0007166)	2495	481	364.41	+	1.32	6.52E-09	3.27E-07
production of molecular mediator of immune response (GO:0002440)	141	0	20.59	-	 < 0.01	6.48E-09	3.26E-07
positive regulation of kinase activity (GO:0033674)	614	154	89.68	+	1.72	6.26E-09	3.16E-07
localization of cell (GO:0051674)	1109	245	161.97	+	1.51	6.20E-09	3.15E-07
cell motility (GO:0048870)	1109	245	161.97	+	1.51	6.20E-09	3.14E-07
DNA repair (GO:0006281)	531	30	77.56	-	.39	5.84E-09	2.98E-07
negative regulation of cellular biosynthetic process (GO:0031327)	1610	333	235.15	+	1.42	5.27E-09	2.70E-07
digestive tract development (GO:0048565)	126	52	18.40	+	2.83	5.09E-09	2.61E-07
positive regulation of protein phosphorylation (GO:0001934)	838	197	122.39	+	1.61	5.01E-09	2.58E-07
cellular protein catabolic process (GO:0044257)	644	41	94.06	-	.44	4.83E-09	2.50E-07
negative regulation of biosynthetic process (GO:0009890)	1643	339	239.97	+	1.41	4.73E-09	2.45E-07
regulation of neurotransmitter levels (GO:0001505)	218	74	31.84	+	2.32	4.66E-09	2.42E-07
cellular response to growth factor stimulus (GO:0071363)	497	132	72.59	+	1.82	4.52E-09	2.36E-07
striated muscle tissue development (GO:0014706)	286	89	41.77	+	2.13	4.44E-09	2.33E-07
negative regulation of cell population proliferation (GO:0008285)	703	172	102.68	+	1.68	4.24E-09	2.22E-07
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	1540	322	224.92	+	1.43	4.03E-09	2.12E-07
limbic system development (GO:0021761)	109	48	15.92	+	3.02	3.79E-09	2.00E-07
nephron epithelium development (GO:0072009)	98	45	14.31	+	3.14	3.72E-09	1.98E-07
negative regulation of macromolecule biosynthetic process (GO:0010558)	1551	324	226.53	+	1.43	3.65E-09	1.94E-07
regulation of macromolecule metabolic process (GO:0060255)	6340	1089	925.99	+	1.18	3.42E-09	1.83E-07
metanephros development (GO:0001656)	79	40	11.54	+	3.47	3.23E-09	1.73E-07
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	134	55	19.57	+	2.81	2.02E-09	1.08E-07
regulation of cellular macromolecule biosynthetic process (GO:2000112)	3968	723	579.55	+	1.25	1.98E-09	1.07E-07
cell projection organization (GO:0030030)	1221	268	178.33	+	1.50	1.94E-09	1.05E-07
detection of stimulus involved in sensory perception (GO:0050906)	557	31	81.35	-	.38	1.85E-09	1.00E-07
calcium ion homeostasis (GO:0055074)	438	122	63.97	+	1.91	1.72E-09	9.37E-08
adaptive immune response (GO:0002250)	658	41	96.10	-	.43	1.63E-09	8.94E-08
regulation of macromolecule biosynthetic process (GO:0010556)	3999	729	584.07	+	1.25	1.63E-09	8.92E-08
regulation of phosphorylation (GO:0042325)	1391	299	203.16	+	1.47	1.54E-09	8.48E-08
mesenchyme development (GO:0060485)	224	77	32.72	+	2.35	1.51E-09	8.33E-08
response to growth factor (GO:0070848)	526	140	76.82	+	1.82	1.35E-09	7.50E-08
cellular divalent inorganic cation homeostasis (GO:0072503)	460	127	67.19	+	1.89	1.25E-09	6.96E-08
RNA splicing, via transesterification reactions (GO:0000375)	306	9	44.69	-	.20	1.23E-09	6.85E-08
mRNA splicing, via spliceosome (GO:0000398)	303	9	44.25	-	.20	1.16E-09	6.51E-08
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	303	9	44.25	-	.20	1.16E-09	6.49E-08
regulation of protein phosphorylation (GO:0001932)	1218	269	177.89	+	1.51	1.13E-09	6.39E-08
cellular response to organic substance (GO:0071310)	2344	462	342.35	+	1.35	1.04E-09	5.89E-08
mRNA processing (GO:0006397)	486	24	70.98	-	.34	9.97E-10	5.67E-08
regulation of cellular biosynthetic process (GO:0031326)	4163	757	608.03	+	1.25	9.92E-10	5.66E-08
regulation of molecular function (GO:0065009)	3118	590	455.40	+	1.30	9.05E-10	5.18E-08
positive regulation of phosphorylation (GO:0042327)	921	216	134.52	+	1.61	8.34E-10	4.79E-08
vascular process in circulatory system (GO:0003018)	251	84	36.66	+	2.29	8.05E-10	4.64E-08
plasma membrane bounded cell projection organization (GO:0120036)	1175	262	171.61	+	1.53	8.01E-10	4.64E-08
learning or memory (GO:0007611)	256	85	37.39	+	2.27	7.12E-10	4.14E-08
muscle tissue development (GO:0060537)	301	95	43.96	+	2.16	6.63E-10	3.87E-08
positive regulation of phosphorus metabolic process (GO:0010562)	998	231	145.76	+	1.58	6.34E-10	3.73E-08
positive regulation of phosphate metabolic process (GO:0045937)	998	231	145.76	+	1.58	6.34E-10	3.71E-08
digestive system development (GO:0055123)	136	57	19.86	+	2.87	6.09E-10	3.59E-08
regulation of growth (GO:0040008)	661	168	96.54	+	1.74	5.84E-10	3.46E-08
regulation of biosynthetic process (GO:0009889)	4226	769	617.23	+	1.25	5.77E-10	3.43E-08
enzyme linked receptor protein signaling pathway (GO:0007167)	723	180	105.60	+	1.70	5.68E-10	3.39E-08
peptide biosynthetic process (GO:0043043)	414	17	60.47	-	.28	5.13E-10	3.07E-08
regulation of metabolic process (GO:0019222)	6874	1179	1003.98	+	1.17	4.90E-10	2.95E-08
embryonic skeletal system development (GO:0048706)	123	54	17.96	+	3.01	4.18E-10	2.52E-08
spinal cord development (GO:0021510)	100	48	14.61	+	3.29	3.63E-10	2.20E-08
positive regulation of nervous system development (GO:0051962)	274	90	40.02	+	2.25	3.36E-10	2.04E-08
kidney epithelium development (GO:0072073)	126	55	18.40	+	2.99	3.34E-10	2.04E-08
negative regulation of signal transduction (GO:0009968)	1305	288	190.60	+	1.51	3.19E-10	1.96E-08
regulation of cellular metabolic process (GO:0031323)	6138	1069	896.48	+	1.19	2.98E-10	1.83E-08
ion homeostasis (GO:0050801)	773	191	112.90	+	1.69	2.88E-10	1.78E-08
potassium ion transport (GO:0006813)	167	66	24.39	+	2.71	2.66E-10	1.65E-08
protein-containing complex subunit organization (GO:0043933)	1605	142	234.42	-	.61	2.60E-10	1.62E-08
regulation of peptide hormone secretion (GO:0090276)	222	79	32.42	+	2.44	2.54E-10	1.59E-08
negative regulation of RNA metabolic process (GO:0051253)	1408	307	205.65	+	1.49	2.28E-10	1.43E-08
DNA metabolic process (GO:0006259)	777	50	113.48	-	.44	1.94E-10	1.22E-08
response to organic cyclic compound (GO:0014070)	900	216	131.45	+	1.64	1.72E-10	1.09E-08
chemical homeostasis (GO:0048878)	1139	260	166.36	+	1.56	1.60E-10	1.01E-08
inner ear development (GO:0048839)	195	73	28.48	+	2.56	1.45E-10	9.24E-09
nephron development (GO:0072006)	126	56	18.40	+	3.04	1.44E-10	9.20E-09
regulation of peptide transport (GO:0090087)	228	81	33.30	+	2.43	1.40E-10	8.99E-09
ribonucleoprotein complex biogenesis (GO:0022613)	462	20	67.48	-	.30	1.26E-10	8.13E-09
cell migration (GO:0016477)	968	229	141.38	+	1.62	1.21E-10	7.83E-09
regulation of peptide secretion (GO:0002791)	226	81	33.01	+	2.45	1.18E-10	7.68E-09
synapse organization (GO:0050808)	289	95	42.21	+	2.25	1.17E-10	7.65E-09
endocrine system development (GO:0035270)	124	56	18.11	+	3.09	9.99E-11	6.55E-09
organelle organization (GO:0006996)	3567	383	520.98	-	.74	9.93E-11	6.54E-09
epithelial tube morphogenesis (GO:0060562)	309	100	45.13	+	2.22	9.77E-11	6.46E-09
response to lipid (GO:0033993)	831	204	121.37	+	1.68	9.55E-11	6.34E-09
cellular macromolecule metabolic process (GO:0044260)	4909	559	716.98	-	.78	8.82E-11	5.94E-09
regulation of nitrogen compound metabolic process (GO:0051171)	5740	1013	838.35	+	1.21	8.84E-11	5.92E-09
regulation of transporter activity (GO:0032409)	300	98	43.82	+	2.24	8.86E-11	5.91E-09
regulation of transmembrane transporter activity (GO:0022898)	283	94	41.33	+	2.27	8.29E-11	5.60E-09
heart morphogenesis (GO:0003007)	241	85	35.20	+	2.41	7.84E-11	5.32E-09
metabolic process (GO:0008152)	8313	1028	1214.15	-	.85	7.40E-11	5.04E-09
positive regulation of cell population proliferation (GO:0008284)	939	225	137.15	+	1.64	6.70E-11	4.59E-09
response to chemical (GO:0042221)	4381	802	639.87	+	1.25	6.19E-11	4.27E-09
regulation of ion transmembrane transporter activity (GO:0032412)	272	92	39.73	+	2.32	6.19E-11	4.25E-09
divalent inorganic cation homeostasis (GO:0072507)	481	137	70.25	+	1.95	5.56E-11	3.85E-09
gland development (GO:0048732)	414	123	60.47	+	2.03	5.24E-11	3.65E-09
response to stimulus (GO:0050896)	8540	1439	1247.31	+	1.15	5.20E-11	3.64E-09
regulation of primary metabolic process (GO:0080090)	5925	1044	865.38	+	1.21	4.85E-11	3.40E-09
positive regulation of ion transport (GO:0043270)	297	98	43.38	+	2.26	4.62E-11	3.26E-09
regulation of RNA metabolic process (GO:0051252)	3782	708	552.38	+	1.28	4.13E-11	2.92E-09
cell junction organization (GO:0034330)	502	142	73.32	+	1.94	3.99E-11	2.84E-09
translation (GO:0006412)	387	13	56.52	-	.23	3.92E-11	2.80E-09
reproductive structure development (GO:0048608)	416	124	60.76	+	2.04	3.73E-11	2.68E-09
neuron migration (GO:0001764)	117	55	17.09	+	3.22	3.61E-11	2.62E-09
regulation of blood circulation (GO:1903522)	278	94	40.60	+	2.32	3.62E-11	2.62E-09
transmembrane transport (GO:0055085)	1276	288	186.37	+	1.55	3.57E-11	2.60E-09
visual system development (GO:0150063)	368	114	53.75	+	2.12	3.03E-11	2.22E-09
regulation of hormone secretion (GO:0046883)	276	94	40.31	+	2.33	2.88E-11	2.13E-09
cognition (GO:0050890)	298	99	43.52	+	2.27	2.90E-11	2.13E-09
reproductive system development (GO:0061458)	419	125	61.20	+	2.04	2.85E-11	2.11E-09
locomotory behavior (GO:0007626)	181	72	26.44	+	2.72	2.77E-11	2.07E-09
potassium ion transmembrane transport (GO:0071805)	158	66	23.08	+	2.86	2.70E-11	2.02E-09
eye development (GO:0001654)	364	114	53.16	+	2.14	2.25E-11	1.69E-09
regulation of cell projection organization (GO:0031344)	648	172	94.64	+	1.82	1.87E-11	1.42E-09
ncRNA processing (GO:0034470)	436	16	63.68	-	.25	1.64E-11	1.24E-09
telencephalon development (GO:0021537)	254	90	37.10	+	2.43	1.47E-11	1.12E-09
neuron fate commitment (GO:0048663)	62	40	9.06	+	4.42	1.45E-11	1.12E-09
regulation of cation channel activity (GO:2001257)	186	74	27.17	+	2.72	1.36E-11	1.05E-09
regulation of neuron projection development (GO:0010975)	447	132	65.29	+	2.02	1.32E-11	1.03E-09
positive regulation of transport (GO:0051050)	947	230	138.31	+	1.66	1.33E-11	1.03E-09
inorganic cation transmembrane transport (GO:0098662)	573	158	83.69	+	1.89	1.27E-11	9.91E-10
biological_process (GO:0008150)	17851	2736	2607.23	+	1.05	1.05E-11	8.31E-10
Unclassified (UNCLASSIFIED)	2744	272	400.77	-	.68	1.05E-11	8.26E-10
sensory system development (GO:0048880)	374	117	54.62	+	2.14	1.03E-11	8.25E-10
regulation of plasma membrane bounded cell projection organization (GO:0120035)	631	170	92.16	+	1.84	1.03E-11	8.21E-10
negative regulation of RNA biosynthetic process (GO:1902679)	1301	296	190.02	+	1.56	8.40E-12	6.74E-10
cellular response to stimulus (GO:0051716)	6807	1186	994.20	+	1.19	8.33E-12	6.71E-10
negative regulation of nucleic acid-templated transcription (GO:1903507)	1299	296	189.73	+	1.56	8.09E-12	6.56E-10
embryo development ending in birth or egg hatching (GO:0009792)	633	171	92.45	+	1.85	7.65E-12	6.23E-10
organic substance metabolic process (GO:0071704)	7840	952	1145.07	-	.83	7.36E-12	6.03E-10
cellular protein-containing complex assembly (GO:0034622)	867	55	126.63	-	.43	7.26E-12	5.98E-10
ear development (GO:0043583)	220	83	32.13	+	2.58	6.78E-12	5.61E-10
cellular response to chemical stimulus (GO:0070887)	2914	573	425.60	+	1.35	6.73E-12	5.60E-10
negative regulation of transcription, DNA-templated (GO:0045892)	1297	296	189.43	+	1.56	6.06E-12	5.06E-10
camera-type eye development (GO:0043010)	317	106	46.30	+	2.29	5.15E-12	4.33E-10
cation transmembrane transport (GO:0098655)	641	173	93.62	+	1.85	5.07E-12	4.29E-10
blood vessel morphogenesis (GO:0048514)	410	126	59.88	+	2.10	4.72E-12	4.01E-10
ncRNA metabolic process (GO:0034660)	521	22	76.09	-	.29	4.15E-12	3.55E-10
chordate embryonic development (GO:0043009)	613	168	89.53	+	1.88	3.90E-12	3.35E-10
cellular response to endogenous stimulus (GO:0071495)	1152	271	168.26	+	1.61	3.28E-12	2.85E-10
muscle structure development (GO:0061061)	473	140	69.08	+	2.03	3.29E-12	2.84E-10
negative regulation of transcription by RNA polymerase II (GO:0000122)	906	226	132.33	+	1.71	2.71E-12	2.37E-10
response to organic substance (GO:0010033)	3008	592	439.33	+	1.35	2.24E-12	1.97E-10
regulation of hormone levels (GO:0010817)	538	154	78.58	+	1.96	2.16E-12	1.91E-10
neuropeptide signaling pathway (GO:0007218)	109	56	15.92	+	3.52	1.61E-12	1.43E-10
vasculature development (GO:0001944)	514	150	75.07	+	2.00	1.16E-12	1.04E-10
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1941	414	283.49	+	1.46	1.06E-12	9.56E-11
morphogenesis of an epithelium (GO:0002009)	441	135	64.41	+	2.10	1.04E-12	9.46E-11
kidney development (GO:0001822)	282	100	41.19	+	2.43	1.04E-12	9.42E-11
blood circulation (GO:0008015)	390	124	56.96	+	2.18	9.82E-13	8.98E-11
blood vessel development (GO:0001568)	492	146	71.86	+	2.03	9.57E-13	8.79E-11
negative regulation of cell communication (GO:0010648)	1401	320	204.62	+	1.56	7.66E-13	7.08E-11
regulation of transcription, DNA-templated (GO:0006355)	3474	672	507.39	+	1.32	7.51E-13	7.06E-11
regulation of nucleic acid-templated transcription (GO:1903506)	3475	672	507.54	+	1.32	7.59E-13	7.06E-11
taxis (GO:0042330)	550	158	80.33	+	1.97	7.51E-13	7.03E-11
macromolecule catabolic process (GO:0009057)	1058	71	154.53	-	.46	6.58E-13	6.23E-11
chemotaxis (GO:0006935)	547	158	79.89	+	1.98	6.18E-13	5.88E-11
cation transport (GO:0006812)	824	213	120.35	+	1.77	6.03E-13	5.77E-11
regulation of RNA biosynthetic process (GO:2001141)	3480	674	508.27	+	1.33	5.37E-13	5.18E-11
cellular metabolic process (GO:0044237)	7542	900	1101.55	-	.82	4.61E-13	4.47E-11
cell fate specification (GO:0001708)	81	49	11.83	+	4.14	4.55E-13	4.44E-11
regulation of cell development (GO:0060284)	500	149	73.03	+	2.04	3.89E-13	3.82E-11
regulation of cell migration (GO:0030334)	892	227	130.28	+	1.74	3.75E-13	3.71E-11
negative regulation of signaling (GO:0023057)	1405	322	205.21	+	1.57	3.71E-13	3.68E-11
regulation of cell motility (GO:2000145)	954	239	139.34	+	1.72	3.61E-13	3.61E-11
cell adhesion (GO:0007155)	953	239	139.19	+	1.72	3.51E-13	3.54E-11
response to oxygen-containing compound (GO:1901700)	1604	358	234.27	+	1.53	3.39E-13	3.43E-11
positive regulation of signaling (GO:0023056)	1761	386	257.20	+	1.50	3.06E-13	3.14E-11
biological adhesion (GO:0022610)	959	240	140.07	+	1.71	3.07E-13	3.13E-11
movement of cell or subcellular component (GO:0006928)	1596	357	233.10	+	1.53	3.00E-13	3.10E-11
sensory organ morphogenesis (GO:0090596)	261	97	38.12	+	2.54	2.92E-13	3.03E-11
external encapsulating structure organization (GO:0045229)	386	125	56.38	+	2.22	2.88E-13	3.01E-11
positive regulation of cell communication (GO:0010647)	1755	385	256.33	+	1.50	2.85E-13	3.01E-11
skeletal system morphogenesis (GO:0048705)	224	88	32.72	+	2.69	2.57E-13	2.73E-11
extracellular structure organization (GO:0043062)	384	125	56.09	+	2.23	2.47E-13	2.64E-11
extracellular matrix organization (GO:0030198)	383	125	55.94	+	2.23	2.34E-13	2.52E-11
positive regulation of macromolecule biosynthetic process (GO:0010557)	1863	405	272.10	+	1.49	2.03E-13	2.22E-11
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	222	88	32.42	+	2.71	2.03E-13	2.20E-11
regulation of neurogenesis (GO:0050767)	364	121	53.16	+	2.28	1.79E-13	1.96E-11
regulation of cation transmembrane transport (GO:1904062)	378	124	55.21	+	2.25	1.71E-13	1.90E-11
positive regulation of biosynthetic process (GO:0009891)	2004	430	292.69	+	1.47	1.65E-13	1.83E-11
regulation of neuron differentiation (GO:0045664)	193	81	28.19	+	2.87	1.59E-13	1.79E-11
inorganic ion transmembrane transport (GO:0098660)	637	179	93.04	+	1.92	1.35E-13	1.53E-11
positive regulation of cellular biosynthetic process (GO:0031328)	1969	425	287.58	+	1.48	1.09E-13	1.24E-11
regulation of cellular component movement (GO:0051270)	1032	256	150.73	+	1.70	1.04E-13	1.19E-11
axon guidance (GO:0007411)	277	102	40.46	+	2.52	7.78E-14	8.98E-12
negative regulation of response to stimulus (GO:0048585)	1831	402	267.43	+	1.50	6.54E-14	7.60E-12
circulatory system process (GO:0003013)	481	148	70.25	+	2.11	6.11E-14	7.15E-12
macromolecule metabolic process (GO:0043170)	6151	701	898.38	-	.78	4.86E-14	5.74E-12
sensory perception of chemical stimulus (GO:0007606)	543	20	79.31	-	.25	4.49E-14	5.38E-12
neuron projection guidance (GO:0097485)	278	103	40.60	+	2.54	4.50E-14	5.35E-12
heart development (GO:0007507)	535	160	78.14	+	2.05	4.32E-14	5.21E-12
regulation of anatomical structure morphogenesis (GO:0022603)	967	246	141.24	+	1.74	3.68E-14	4.48E-12
signal transduction (GO:0007165)	5227	963	763.43	+	1.26	3.49E-14	4.28E-12
primary metabolic process (GO:0044238)	7352	864	1073.80	-	.80	3.20E-14	3.95E-12
response to endogenous stimulus (GO:0009719)	1426	332	208.27	+	1.59	2.53E-14	3.14E-12
cellular process (GO:0009987)	15495	2450	2263.12	+	1.08	2.43E-14	3.05E-12
epithelium development (GO:0060429)	1113	275	162.56	+	1.69	2.10E-14	2.66E-12
regulation of secretion by cell (GO:1903530)	581	171	84.86	+	2.02	1.91E-14	2.43E-12
system process (GO:0003008)	2057	445	300.43	+	1.48	1.75E-14	2.24E-12
renal system development (GO:0072001)	291	108	42.50	+	2.54	1.43E-14	1.85E-12
nitrogen compound metabolic process (GO:0006807)	6886	797	1005.73	-	.79	1.41E-14	1.84E-12
cellular macromolecule catabolic process (GO:0044265)	925	53	135.10	-	.39	1.23E-14	1.62E-12
ion transmembrane transport (GO:0034220)	870	230	127.07	+	1.81	8.90E-15	1.18E-12
negative regulation of cell differentiation (GO:0045596)	644	185	94.06	+	1.97	7.62E-15	1.02E-12
locomotion (GO:0040011)	1345	320	196.44	+	1.63	7.25E-15	9.79E-13
cell morphogenesis involved in differentiation (GO:0000904)	559	168	81.64	+	2.06	6.65E-15	9.06E-13
regulation of response to stimulus (GO:0048583)	4306	823	628.91	+	1.31	5.08E-15	6.98E-13
ion transport (GO:0006811)	1200	294	175.27	+	1.68	5.03E-15	6.98E-13
urogenital system development (GO:0001655)	324	117	47.32	+	2.47	4.91E-15	6.86E-13
mRNA metabolic process (GO:0016071)	697	31	101.80	-	.30	4.48E-15	6.33E-13
regulation of locomotion (GO:0040012)	997	256	145.62	+	1.76	4.07E-15	5.79E-13
positive regulation of RNA metabolic process (GO:0051254)	1773	399	258.96	+	1.54	3.60E-15	5.18E-13
positive regulation of macromolecule metabolic process (GO:0010604)	3522	697	514.41	+	1.35	3.05E-15	4.42E-13
organic cyclic compound metabolic process (GO:1901360)	3182	306	464.75	-	.66	2.46E-15	3.60E-13
positive regulation of nitrogen compound metabolic process (GO:0051173)	3123	632	456.13	+	1.39	2.37E-15	3.51E-13
cell morphogenesis involved in neuron differentiation (GO:0048667)	453	147	66.16	+	2.22	1.86E-15	2.81E-13
cell part morphogenesis (GO:0032990)	526	163	76.82	+	2.12	1.88E-15	2.80E-13
axonogenesis (GO:0007409)	385	132	56.23	+	2.35	1.70E-15	2.58E-13
negative regulation of multicellular organismal process (GO:0051241)	1014	261	148.10	+	1.76	1.67E-15	2.57E-13
regulation of secretion (GO:0051046)	639	187	93.33	+	2.00	1.19E-15	1.84E-13
anterior/posterior pattern specification (GO:0009952)	203	89	29.65	+	3.00	1.13E-15	1.77E-13
positive regulation of cellular metabolic process (GO:0031325)	3314	666	484.03	+	1.38	1.03E-15	1.63E-13
cellular component morphogenesis (GO:0032989)	611	182	89.24	+	2.04	7.39E-16	1.18E-13
regulation of membrane potential (GO:0042391)	437	145	63.83	+	2.27	6.51E-16	1.05E-13
central nervous system neuron differentiation (GO:0021953)	183	85	26.73	+	3.18	4.18E-16	6.89E-14
RNA metabolic process (GO:0016070)	1582	116	231.06	-	.50	4.21E-16	6.86E-14
regulation of transmembrane transport (GO:0034762)	591	179	86.32	+	2.07	4.05E-16	6.74E-14
axon development (GO:0061564)	421	142	61.49	+	2.31	3.89E-16	6.55E-14
cell projection morphogenesis (GO:0048858)	507	162	74.05	+	2.19	2.49E-16	4.24E-14
regulation of nervous system development (GO:0051960)	443	148	64.70	+	2.29	2.11E-16	3.62E-14
plasma membrane bounded cell projection morphogenesis (GO:0120039)	503	162	73.47	+	2.21	1.21E-16	2.10E-14
skeletal system development (GO:0001501)	479	157	69.96	+	2.24	1.15E-16	2.01E-14
detection of chemical stimulus (GO:0009593)	522	14	76.24	-	.18	6.32E-17	1.12E-14
neuron projection morphogenesis (GO:0048812)	499	162	72.88	+	2.22	5.97E-17	1.09E-14
positive regulation of metabolic process (GO:0009893)	3820	758	557.93	+	1.36	6.03E-17	1.08E-14
tissue morphogenesis (GO:0048729)	545	172	79.60	+	2.16	5.60E-17	1.03E-14
cellular aromatic compound metabolic process (GO:0006725)	2937	268	428.96	-	.62	5.51E-17	1.02E-14
sensory perception of smell (GO:0007608)	468	10	68.35	-	.15	5.02E-17	9.46E-15
neuron projection development (GO:0031175)	691	204	100.92	+	2.02	3.16E-17	6.02E-15
cell morphogenesis (GO:0000902)	715	209	104.43	+	2.00	2.70E-17	5.20E-15
regulation of ion transmembrane transport (GO:0034765)	502	164	73.32	+	2.24	2.61E-17	5.09E-15
positive regulation of RNA biosynthetic process (GO:1902680)	1629	385	237.92	+	1.62	1.88E-17	3.71E-15
positive regulation of nucleic acid-templated transcription (GO:1903508)	1628	385	237.78	+	1.62	1.82E-17	3.69E-15
positive regulation of transcription, DNA-templated (GO:0045893)	1628	385	237.78	+	1.62	1.82E-17	3.64E-15
embryonic organ morphogenesis (GO:0048562)	295	117	43.09	+	2.72	1.45E-17	2.97E-15
forebrain development (GO:0030900)	387	140	56.52	+	2.48	8.16E-18	1.70E-15
gene expression (GO:0010467)	2117	168	309.20	-	.54	6.28E-18	1.32E-15
chemical synaptic transmission (GO:0007268)	414	147	60.47	+	2.43	3.07E-18	6.74E-16
negative regulation of developmental process (GO:0051093)	879	246	128.38	+	1.92	3.11E-18	6.65E-16
anterograde trans-synaptic signaling (GO:0098916)	414	147	60.47	+	2.43	3.07E-18	6.65E-16
regulation of transcription by RNA polymerase II (GO:0006357)	2595	561	379.01	+	1.48	2.14E-18	4.76E-16
synaptic signaling (GO:0099536)	464	161	67.77	+	2.38	6.49E-19	1.46E-16
RNA processing (GO:0006396)	930	43	135.83	-	.32	5.23E-19	1.20E-16
positive regulation of transcription by RNA polymerase II (GO:0045944)	1212	315	177.02	+	1.78	4.50E-19	1.05E-16
cellular nitrogen compound metabolic process (GO:0034641)	3395	313	495.86	-	.63	4.08E-19	9.64E-17
tube morphogenesis (GO:0035239)	654	203	95.52	+	2.13	3.50E-19	8.37E-17
regulation of signal transduction (GO:0009966)	3128	657	456.86	+	1.44	3.07E-19	7.47E-17
regulation of system process (GO:0044057)	585	189	85.44	+	2.21	2.71E-19	6.70E-17
regulation of cell population proliferation (GO:0042127)	1654	399	241.57	+	1.65	2.43E-19	6.09E-17
trans-synaptic signaling (GO:0099537)	432	155	63.10	+	2.46	1.61E-19	4.11E-17
nucleobase-containing compound metabolic process (GO:0006139)	2705	228	395.08	-	.58	9.49E-20	2.46E-17
regulation of trans-synaptic signaling (GO:0099177)	432	156	63.10	+	2.47	8.30E-20	2.19E-17
modulation of chemical synaptic transmission (GO:0050804)	431	156	62.95	+	2.48	7.43E-20	1.99E-17
circulatory system development (GO:0072359)	877	253	128.09	+	1.98	3.41E-20	9.30E-18
heterocycle metabolic process (GO:0046483)	2891	247	422.24	-	.58	1.94E-20	5.37E-18
embryonic organ development (GO:0048568)	435	160	63.53	+	2.52	6.20E-21	1.75E-18
cell communication (GO:0007154)	5656	1085	826.09	+	1.31	1.04E-21	2.99E-19
neuron development (GO:0048666)	846	253	123.56	+	2.05	6.35E-22	1.86E-19
positive regulation of cell differentiation (GO:0045597)	840	253	122.69	+	2.06	2.97E-22	8.86E-20
embryonic morphogenesis (GO:0048598)	570	196	83.25	+	2.35	1.28E-22	3.90E-20
sensory organ development (GO:0007423)	555	193	81.06	+	2.38	1.16E-22	3.59E-20
anatomical structure formation involved in morphogenesis (GO:0048646)	883	264	128.97	+	2.05	7.37E-23	2.33E-20
negative regulation of cellular process (GO:0048523)	4902	972	715.96	+	1.36	7.16E-23	2.31E-20
signaling (GO:0023052)	5565	1081	812.80	+	1.33	2.70E-23	8.90E-21
brain development (GO:0007420)	759	240	110.86	+	2.16	2.34E-23	7.88E-21
positive regulation of multicellular organismal process (GO:0051240)	1431	375	209.00	+	1.79	2.26E-23	7.77E-21
detection of chemical stimulus involved in sensory perception (GO:0050907)	486	4	70.98	-	.06	1.23E-23	4.33E-21
behavior (GO:0007610)	557	197	81.35	+	2.42	8.87E-24	3.18E-21
nucleic acid metabolic process (GO:0090304)	2217	158	323.80	-	.49	5.97E-24	2.20E-21
negative regulation of biological process (GO:0048519)	5501	1078	803.45	+	1.34	2.10E-24	7.92E-22
tube development (GO:0035295)	856	265	125.02	+	2.12	1.13E-24	4.36E-22
cell fate commitment (GO:0045165)	238	120	34.76	+	3.45	1.10E-24	4.34E-22
head development (GO:0060322)	803	254	117.28	+	2.17	9.73E-25	3.94E-22
tissue development (GO:0009888)	1729	438	252.53	+	1.73	7.96E-25	3.31E-22
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	441	1	64.41	-	.02	5.07E-25	2.17E-22
regulation of ion transport (GO:0043269)	703	234	102.68	+	2.28	2.64E-25	1.16E-22
regionalization (GO:0003002)	317	143	46.30	+	3.09	2.11E-25	9.55E-23
regulation of transport (GO:0051049)	1772	451	258.81	+	1.74	5.53E-26	2.57E-23
regulation of multicellular organismal development (GO:2000026)	1332	367	194.55	+	1.89	4.04E-26	1.94E-23
positive regulation of developmental process (GO:0051094)	1271	356	185.64	+	1.92	2.06E-26	1.02E-23
positive regulation of biological process (GO:0048518)	6331	1224	924.67	+	1.32	6.53E-27	3.33E-24
embryo development (GO:0009790)	991	303	144.74	+	2.09	1.53E-27	8.35E-25
regulation of cell differentiation (GO:0045595)	1586	422	231.64	+	1.82	1.54E-27	8.13E-25
positive regulation of cellular process (GO:0048522)	5741	1135	838.50	+	1.35	1.43E-27	8.05E-25
regulation of biological quality (GO:0065008)	3995	851	583.49	+	1.46	1.23E-27	7.19E-25
cell development (GO:0048468)	1646	437	240.41	+	1.82	2.33E-28	1.42E-25
pattern specification process (GO:0007389)	426	179	62.22	+	2.88	1.38E-28	8.70E-26
regulation of cell communication (GO:0010646)	3509	777	512.51	+	1.52	3.24E-29	2.13E-26
regulation of signaling (GO:0023051)	3545	789	517.76	+	1.52	2.28E-30	1.57E-27
regulation of cellular process (GO:0050794)	11351	1993	1657.87	+	1.20	2.95E-31	2.12E-28
cell-cell signaling (GO:0007267)	1131	346	165.19	+	2.09	1.97E-31	1.48E-28
regulation of biological process (GO:0050789)	11898	2071	1737.76	+	1.19	1.42E-31	1.12E-28
central nervous system development (GO:0007417)	1000	326	146.05	+	2.23	7.38E-34	6.14E-31
regulation of localization (GO:0032879)	2753	668	402.09	+	1.66	2.97E-34	2.61E-31
biological regulation (GO:0065007)	12568	2177	1835.62	+	1.19	2.55E-34	2.37E-31
regulation of developmental process (GO:0050793)	2461	621	359.44	+	1.73	1.05E-35	1.03E-32
neuron differentiation (GO:0030182)	1043	348	152.34	+	2.28	8.03E-38	8.46E-35
regulation of multicellular organismal process (GO:0051239)	2673	677	390.40	+	1.73	6.13E-40	6.92E-37
animal organ morphogenesis (GO:0009887)	956	336	139.63	+	2.41	3.65E-40	4.44E-37
generation of neurons (GO:0048699)	1271	412	185.64	+	2.22	1.34E-42	1.77E-39
neurogenesis (GO:0022008)	1391	438	203.16	+	2.16	9.41E-43	1.35E-39
cellular developmental process (GO:0048869)	3634	895	530.76	+	1.69	7.48E-51	1.18E-47
cell differentiation (GO:0030154)	3575	888	522.15	+	1.70	9.13E-52	1.60E-48
animal organ development (GO:0048513)	3220	829	470.30	+	1.76	3.76E-53	7.42E-50
anatomical structure morphogenesis (GO:0009653)	2158	640	315.19	+	2.03	9.11E-57	2.06E-53
nervous system development (GO:0007399)	2218	676	323.95	+	2.09	3.40E-64	8.95E-61
multicellular organismal process (GO:0032501)	6926	1502	1011.58	+	1.48	1.32E-65	4.17E-62
developmental process (GO:0032502)	5797	1358	846.68	+	1.60	1.79E-75	7.07E-72
system development (GO:0048731)	4330	1116	632.42	+	1.76	1.23E-77	6.48E-74
multicellular organism development (GO:0007275)	4941	1224	721.66	+	1.70	3.29E-78	2.60E-74
anatomical structure development (GO:0048856)	5330	1293	778.47	+	1.66	4.79E-79	7.57E-75
